Page
|
||
A
|
Income & expenses
|
34
|
B
|
IFRS financial statements and notes
|
39
|
C
|
Capital & liquidity
|
93
|
D
|
Analysis of assets
|
103
|
E
|
VNB & Sales analysis
|
125
|
F
|
MCEV financial statements and notes
|
131
|
In this section
|
||
A
|
Income & expenses
|
34
|
Reconciliation of Group operating profit to profit after tax - IFRS basis
|
34
|
|
A1
|
Other operations
|
35
|
A2
|
Corporate centre
|
35
|
A3
|
Group debt costs and other interest
|
35
|
A4
|
Life business: Investment return variances and economic assumption changes
|
36
|
A5
|
Non-life business: Short-term fluctuation in return on investments
|
37
|
A6
|
General insurance and health business: Economic assumption changes
|
37
|
A7
|
Impairment of goodwill, associates, joint ventures and other amounts expensed
|
38
|
A8
|
Amortisation and impairment of acquired value of in-force business
|
38
|
A9
|
Profit/loss on the disposal and re-measurement of subsidiaries, joint ventures and associates
|
38
|
A10
|
Other
|
38
|
2015
£m
|
Restated1
2014
£m
|
|
Operating profit before tax attributable to shareholders' profits
|
||
Life business
|
||
United Kingdom & Ireland
|
1,432
|
1,049
|
Europe
|
766
|
882
|
Asia
|
244
|
87
|
Other
|
(23)
|
1
|
Total life business
|
2,419
|
2,019
|
General insurance and health
|
||
United Kingdom & Ireland
|
430
|
499
|
Europe
|
114
|
113
|
Canada
|
214
|
189
|
Asia
|
(6)
|
(2)
|
Other
|
13
|
9
|
Total general insurance and health
|
765
|
808
|
Fund management
|
||
Aviva Investors
|
105
|
79
|
United Kingdom
|
-
|
6
|
Asia
|
1
|
1
|
Total fund management
|
106
|
86
|
Other
|
||
Other operations (note A1)
|
(84)
|
(105)
|
Market operating profit
|
3,206
|
2,808
|
Corporate centre (note A2)
|
(180)
|
(132)
|
Group debt costs and other interest (note A3)
|
(361)
|
(463)
|
Operating profit before tax attributable to shareholders' profits
|
2,665
|
2,213
|
Integration and restructuring costs
|
(379)
|
(140)
|
Operating profit before tax attributable to shareholders' profits after integration and restructuring costs
|
2,286
|
2,073
|
Adjusted for the following:
|
||
Investment return variances and economic assumption changes on long-term business (note A4)
|
14
|
72
|
Short-term fluctuation in return on investments backing non-long-term business (note A5)
|
(84)
|
261
|
Economic assumption changes on general insurance and health business (note A6)
|
(100)
|
(145)
|
Impairment of goodwill, joint ventures and associates and other amounts expensed (note A7)
|
(22)
|
(24)
|
Amortisation and impairment of intangibles
|
(155)
|
(90)
|
Amortisation and impairment of acquired value of in-force business (note A8)
|
(498)
|
(40)
|
Profit on the disposal and re-measurement of subsidiaries, joint ventures and associates (note A9)
|
2
|
174
|
Other (note A10)
|
(53)
|
-
|
Non-operating items before tax
|
(896)
|
208
|
Profit before tax attributable to shareholders' profits
|
1,390
|
2,281
|
Tax on operating profit
|
(598)
|
(563)
|
Tax on other activities
|
287
|
(38)
|
(311)
|
(601)
|
|
Profit after tax
|
1,079
|
1,680
|
Profit from discontinued operations2
|
-
|
58
|
Profit for the year
|
1,079
|
1,738
|
1 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
2 Discontinued operations relate to US life and related internal asset management businesses (US Life) sold in 2013.
|
2015
£m
|
2014
£m
|
|
United Kingdom & Ireland Life
|
(29)
|
(4)
|
United Kingdom & Ireland General Insurance
|
5
|
4
|
Europe
|
(22)
|
(26)
|
Asia
|
(16)
|
(8)
|
Other Group operations1
|
(22)
|
(71)
|
Total
|
(84)
|
(105)
|
1 Other Group operations include Group and head office costs.
|
2015
£m
|
2014
£m
|
|
Project spend
|
(6)
|
(9)
|
Central spend and share award costs
|
(174)
|
(123)
|
Total
|
(180)
|
(132)
|
2015
£m
|
2014
£m
|
|
External debt
|
||
Subordinated debt
|
(335)
|
(289)
|
Other
|
(15)
|
(21)
|
Total external debt
|
(350)
|
(310)
|
Internal lending arrangements
|
(92)
|
(186)
|
Extinguishment of debt
|
(13)
|
-
|
Net finance income on main UK pension scheme
|
94
|
33
|
Total
|
(361)
|
(463)
|
Life business
|
2015
£m
|
2014
£m
|
Investment variances and economic assumptions
|
14
|
72
|
Equities
|
Properties
|
|||
2015
%
|
2014
%
|
2015
%
|
2014
%
|
|
United Kingdom
|
5.4%
|
6.6%
|
3.9%
|
5.1%
|
Eurozone
|
4.3%
|
5.7%
|
2.8%
|
4.2%
|
General Insurance and health
|
2015
£m
|
2014
£m
|
Analysis of investment income:
|
||
- Net investment income
|
240
|
666
|
- Foreign exchange gains/losses and other charges
|
(10)
|
(8)
|
230
|
658
|
|
Analysed between:
|
||
- Longer-term investment return, reported within operating profit
|
396
|
477
|
- Short-term fluctuations in investment return, reported outside operating profit
|
(166)
|
181
|
230
|
658
|
|
Short-term fluctuations:
|
||
- General insurance and health
|
(166)
|
181
|
- Other operations1
|
82
|
80
|
Total short-term fluctuations
|
(84)
|
261
|
|
1 Represents short-term fluctuation on assets backing non-life business in Group centre investments, including the centre hedging programme.
|
2015
£m
|
2014
£m
|
|
Debt securities
|
9,608
|
10,858
|
Equity securities
|
217
|
251
|
Properties
|
335
|
223
|
Cash and cash equivalents
|
969
|
1,300
|
Other1
|
3,008
|
3,767
|
Assets supporting general insurance and health business
|
14,137
|
16,399
|
Assets supporting other non-long-term business2
|
538
|
562
|
Total assets supporting non-long-term business
|
14,675
|
16,961
|
1 Includes the internal loan.
|
2 Represents assets backing non-life business in Group centre investments, including the centre hedging programme.
|
Longer-term rates of
return on equities
|
Longer-term rates of
return on property
|
|||
2015
%
|
2014
%
|
2015
%
|
2014
%
|
|
United Kingdom
|
5.4%
|
6.6%
|
3.9%
|
5.1%
|
Eurozone
|
4.3%
|
5.7%
|
2.8%
|
4.2%
|
Canada
|
5.8%
|
6.8%
|
4.3%
|
5.3%
|
In this section
|
Page
|
|
Consolidated financial statements
|
||
Consolidated income statement
|
40
|
|
Consolidated statement of comprehensive income
|
41
|
|
Consolidated statement of changes in equity
|
42
|
|
Consolidated statement of financial position
|
43
|
|
Consolidated statement of cash flows
|
44
|
|
Notes to the consolidated financial statements
|
||
B1(i)
|
Basis of preparation
|
45
|
B1(ii)
|
New standards, interpretations and amendments to published standards
that have been adopted by the Group
|
45
|
B2
|
Presentation changes
|
46
|
B3
|
Exchange rates
|
46
|
B4
|
Subsidiaries
|
47
|
B5
|
Segmental information
|
50
|
B6
|
Tax
|
58
|
B7
|
Earnings per share
|
60
|
B8
|
Dividends and appropriations
|
61
|
B9
|
Insurance liabilities
|
62
|
B10
|
Liability for investment contracts
|
71
|
B11
|
Reinsurance assets
|
72
|
B12
|
Effect of changes in assumptions and estimates during the year
|
74
|
B13
|
Unallocated divisible surplus
|
74
|
B14
|
Borrowings
|
75
|
B15
|
Pension obligations
|
75
|
B16
|
Cash and cash equivalents
|
77
|
B17
|
Related party transactions
|
78
|
B18
|
Risk management
|
78
|
B19
|
Direct capital instrument and tier 1 notes
|
89
|
B20
|
Contingent liabilities and other risk factors
|
90
|
B21
|
Acquired value of in-force business and intangible assets
|
91
|
B22
|
Subsequent events
|
91
|
Note
|
2015
£m
|
2014
£m
|
|
Income
|
|||
Gross written premiums
|
21,925
|
21,670
|
|
Premiums ceded to reinsurers
|
(2,890)
|
(1,614)
|
|
Premiums written net of reinsurance
|
19,035
|
20,056
|
|
Net change in provision for unearned premiums
|
(111)
|
1
|
|
Net earned premiums
|
18,924
|
20,057
|
|
Fee and commission income
|
1,797
|
1,230
|
|
Net investment income
|
2,825
|
21,889
|
|
Share of profit after tax of joint ventures and associates
|
180
|
147
|
|
Profit on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
2
|
174
|
|
23,728
|
43,497
|
||
Expenses
|
|||
Claims and benefits paid, net of recoveries from reinsurers
|
(21,985)
|
(19,474)
|
|
Change in insurance liabilities, net of reinsurance
|
6,681
|
(5,570)
|
|
Change in investment contract provisions
|
(1,487)
|
(6,518)
|
|
Change in unallocated divisible surplus
|
984
|
(3,364)
|
|
Fee and commission expense
|
(3,347)
|
(3,389)
|
|
Other expenses
|
(2,784)
|
(1,979)
|
|
Finance costs
|
(618)
|
(540)
|
|
(22,556)
|
(40,834)
|
||
Profit before tax
|
1,172
|
2,663
|
|
Tax attributable to policyholders' returns
|
B6
|
218
|
(382)
|
Profit before tax attributable to shareholders' profits
|
1,390
|
2,281
|
|
Tax expense
|
B6
|
(93)
|
(983)
|
Less: tax attributable to policyholders' returns
|
B6
|
(218)
|
382
|
Tax attributable to shareholders' profits
|
(311)
|
(601)
|
|
Profit after tax
|
1,079
|
1,680
|
|
Profit from discontinued operations1
|
-
|
58
|
|
Profit for the year
|
1,079
|
1,738
|
|
Attributable to:
|
|||
Equity holders of Aviva plc
|
918
|
1,569
|
|
Non-controlling interests
|
161
|
169
|
|
Profit for the year
|
1,079
|
1,738
|
|
Earnings per share
|
B7
|
||
Basic (pence per share)
|
22.6p
|
50.4p
|
|
Diluted (pence per share)
|
22.3p
|
49.6p
|
|
Continuing operations - Basic (pence per share)
|
22.6p
|
48.4p
|
|
Continuing operations - Diluted (pence per share)
|
22.3p
|
47.7p
|
1 Discontinued operations relates to the US Life and related internal asset management businesses (US Life) sold in 2013.
|
Note
|
2015
£m
|
2014
£m
|
|
Profit for the year from continuing operations
|
1,079
|
1,680
|
|
Profit for the year from discontinued operations1
|
-
|
58
|
|
Total profit for the year
|
1,079
|
1,738
|
|
Other comprehensive income from continuing operations:
|
|||
Items that may be reclassified subsequently to income statement
|
|||
Investments classified as available for sale
|
|||
Fair value (losses)/gains
|
(9)
|
62
|
|
Fair value losses transferred to profit on disposals
|
-
|
(7)
|
|
Share of other comprehensive income of joint ventures and associates
|
(14)
|
22
|
|
Foreign exchange rate movements
|
(378)
|
(396)
|
|
Aggregate tax effect - shareholder tax on items that may be reclassified into profit or loss
|
13
|
(9)
|
|
Items that will not be reclassified to income statement
|
|||
Owner-occupied properties - fair value gains
|
27
|
7
|
|
Remeasurements of pension schemes
|
B15
|
(235)
|
1,662
|
Aggregate tax effect - shareholder tax on items that will not be reclassified into profit or loss
|
93
|
(347)
|
|
Other comprehensive income, net of tax from continuing operations
|
(503)
|
994
|
|
Other comprehensive income, net of tax from discontinued operations1
|
-
|
-
|
|
Total other comprehensive income, net of tax
|
(503)
|
994
|
|
Total comprehensive income for the year from continuing operations
|
576
|
2,674
|
|
Total comprehensive income for the year from discontinued operations1
|
-
|
58
|
|
Total comprehensive income for the year
|
576
|
2,732
|
|
Attributable to:
|
|||
Equity holders of Aviva plc
|
460
|
2,642
|
|
Non-controlling interests
|
116
|
90
|
|
576
|
2,732
|
1 Discontinued operations relates to the US Life and related internal asset management businesses (US Life) sold in 2013.
|
Ordinary share capital
£m
|
Preference share capital
£m
|
Share premium
£m
|
Merger reserve
£m
|
Treasury shares
£m
|
Other
Reserves
£m
|
Retained earnings
£m
|
Equity attributable to shareholders of Aviva plc
£m
|
DCI and tier 1 notes
£m
|
Non-controlling interests
£m
|
Total
equity
£m
|
|
Balance at 1 January
|
737
|
200
|
1,172
|
3,271
|
(8)
|
229
|
4,617
|
10,218
|
892
|
1,166
|
12,276
|
Profit for the year
|
-
|
-
|
-
|
-
|
-
|
-
|
918
|
918
|
-
|
161
|
1,079
|
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
(316)
|
(142)
|
(458)
|
-
|
(45)
|
(503)
|
Total comprehensive income for the year
|
-
|
-
|
-
|
-
|
-
|
(316)
|
776
|
460
|
-
|
116
|
576
|
Issue of share capital - acquisition of Friends Life
|
272
|
-
|
-
|
5,703
|
-
|
-
|
-
|
5,975
|
-
|
-
|
5,975
|
Non-controlling interests in acquired subsidiaries1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
504
|
504
|
Reclassification of non-controlling interests to financial liabilities2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(272)
|
(272)
|
Reclassification of non-controlling interests to tier 1 notes3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
231
|
(231)
|
-
|
Owner-occupied properties fair value gains transferred to retained earnings on disposals
|
-
|
-
|
-
|
-
|
-
|
(33)
|
33
|
-
|
-
|
-
|
-
|
Dividends and appropriations
|
-
|
-
|
-
|
-
|
-
|
-
|
(724)
|
(724)
|
-
|
-
|
(724)
|
Non-controlling interests share of dividends declared in the year
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(142)
|
(142)
|
Transfer to profit on disposal of subsidiaries, joint ventures and associates
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
-
|
-
|
1
|
Capital contributions from non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
5
|
5
|
Changes in non-controlling interests in subsidiaries
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1)
|
(1)
|
Treasury shares held by subsidiary companies
|
-
|
-
|
-
|
-
|
(27)
|
-
|
-
|
(27)
|
-
|
-
|
(27)
|
Reserves credit for equity compensation plans
|
-
|
-
|
-
|
-
|
-
|
40
|
-
|
40
|
-
|
-
|
40
|
Shares issued under equity compensation plans
|
3
|
-
|
13
|
-
|
6
|
(35)
|
19
|
6
|
-
|
-
|
6
|
Aggregate tax effect - shareholder tax
|
-
|
-
|
-
|
-
|
-
|
-
|
15
|
15
|
-
|
-
|
15
|
Balance at 31 December
|
1,012
|
200
|
1,185
|
8,974
|
(29)
|
(114)
|
4,736
|
15,964
|
1,123
|
1,145
|
18,232
|
1 Includes Friends Life's Step-up Tier one Insurance Capital Securities ('STICS') issuances classified as equity instruments within non-controlling interests at the date of acquisition. See Note B4 for further detail.
|
2 On 29 May 2015, notification was given that the Group would redeem the 2005 STICS issuance. At that date the instrument was reclassified as a financial liability. The instrument was redeemed on 1 July 2015, £272 million represents the fair value of instruments recognised on acquisition, made up of the £268 million outstanding principal redeemed on 1 July 2015 and £4 million amortised subsequent to the reclassification and included within finance costs in the income statement.
|
3 On 1 October 2015 Aviva plc replaced Friends Life Holdings plc as issuer of the 2003 STICS issuance which resulted in a reclassification of the STICS from non-controlling interests to DCI and tier 1 notes.
|
Ordinary share capital
£m
|
Preference share capital
£m
|
Share premium
£m
|
Merger reserve
£m
|
Treasury shares
£m
|
Other
Reserves
£m
|
Retained earnings
£m
|
Equity attributable to shareholders of Aviva plc
£m
|
DCI and tier 1 notes
£m
|
Non-controlling interests
£m
|
Total equity
£m
|
|
Balance at 1 January
|
736
|
200
|
1,165
|
3,271
|
(31)
|
475
|
2,348
|
8,164
|
1,382
|
1,471
|
11,017
|
Profit for the year
|
-
|
-
|
-
|
-
|
-
|
-
|
1,569
|
1,569
|
-
|
169
|
1,738
|
Other comprehensive income
|
-
|
-
|
-
|
-
|
-
|
(242)
|
1,315
|
1,073
|
-
|
(79)
|
994
|
Total comprehensive income for the year
|
-
|
-
|
-
|
-
|
-
|
(242)
|
2,884
|
2,642
|
-
|
90
|
2,732
|
Owner-occupied properties fair value gains transferred to retained earnings on disposals
|
-
|
-
|
-
|
-
|
-
|
(2)
|
2
|
-
|
-
|
-
|
-
|
Dividends and appropriations
|
-
|
-
|
-
|
-
|
-
|
-
|
(551)
|
(551)
|
-
|
-
|
(551)
|
Non-controlling interests share of dividends declared in the year
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(189)
|
(189)
|
Transfer to profit on disposal of subsidiaries, joint ventures and associates
|
-
|
-
|
-
|
-
|
-
|
(13)
|
2
|
(11)
|
-
|
-
|
(11)
|
Changes in non-controlling interests in subsidiaries
|
-
|
-
|
-
|
-
|
-
|
-
|
(36)
|
(36)
|
-
|
(206)
|
(242)
|
Reserves credit for equity compensation plans
|
-
|
-
|
-
|
-
|
-
|
39
|
-
|
39
|
-
|
-
|
39
|
Shares issued under equity compensation plans
|
1
|
-
|
7
|
-
|
23
|
(28)
|
6
|
9
|
-
|
-
|
9
|
Aggregate tax effect - shareholder tax
|
-
|
-
|
-
|
-
|
-
|
-
|
19
|
19
|
-
|
-
|
19
|
Redemption of direct capital instrument1
|
-
|
-
|
-
|
-
|
-
|
-
|
(57)
|
(57)
|
(490)
|
-
|
(547)
|
Balance at 31 December
|
737
|
200
|
1,172
|
3,271
|
(8)
|
229
|
4,617
|
10,218
|
892
|
1,166
|
12,276
|
1 £57 million relates to the foreign exchange loss on redemption of the €700 million direct capital instrument on 28 November 2014.
|
Note
|
2015
£m
|
2014
£m
|
|
Assets
|
|||
Goodwill
|
1,955
|
1,302
|
|
Acquired value of in-force business and intangible assets
|
B21
|
5,731
|
1,028
|
Interests in, and loans to, joint ventures
|
1,590
|
1,140
|
|
Interests in, and loans to, associates
|
329
|
404
|
|
Property and equipment
|
449
|
357
|
|
Investment property
|
11,301
|
8,925
|
|
Loans
|
22,433
|
25,260
|
|
Financial investments
|
274,217
|
202,638
|
|
Reinsurance assets
|
B11
|
20,918
|
7,958
|
Deferred tax assets
|
131
|
76
|
|
Current tax assets
|
114
|
27
|
|
Receivables
|
6,875
|
5,933
|
|
Deferred acquisition costs and other assets
|
5,061
|
5,091
|
|
Prepayments and accrued income
|
3,094
|
2,466
|
|
Cash and cash equivalents
|
B16
|
33,676
|
23,105
|
Assets of operations classified as held for sale
|
B4
|
-
|
9
|
Total assets
|
387,874
|
285,719
|
|
Equity
|
|||
Capital
|
|||
Ordinary share capital
|
1,012
|
737
|
|
Preference share capital
|
200
|
200
|
|
1,212
|
937
|
||
Capital reserves
|
|||
Share premium
|
1,185
|
1,172
|
|
Merger reserve
|
8,974
|
3,271
|
|
10,159
|
4,443
|
||
Treasury shares
|
(29)
|
(8)
|
|
Other reserves
|
(114)
|
229
|
|
Retained earnings
|
4,736
|
4,617
|
|
Equity attributable to shareholders of Aviva plc
|
15,964
|
10,218
|
|
Direct capital instruments and tier 1 notes
|
1,123
|
892
|
|
Equity excluding non-controlling interests
|
17,087
|
11,110
|
|
Non-controlling interests
|
1,145
|
1,166
|
|
Total equity
|
18,232
|
12,276
|
|
Liabilities
|
|||
Gross insurance liabilities
|
B9
|
140,556
|
113,445
|
Gross liabilities for investment contracts
|
B10
|
181,173
|
117,245
|
Unallocated divisible surplus
|
B13
|
8,811
|
9,467
|
Net asset value attributable to unitholders
|
11,415
|
9,482
|
|
Provisions
|
1,416
|
879
|
|
Deferred tax liabilities
|
2,074
|
1,091
|
|
Current tax liabilities
|
177
|
169
|
|
Borrowings
|
B14
|
8,770
|
7,378
|
Payables and other financial liabilities
|
12,448
|
12,012
|
|
Other liabilities
|
2,802
|
2,273
|
|
Liabilities of operations classified as held for sale
|
B4
|
-
|
2
|
Total liabilities
|
369,642
|
273,443
|
|
Total equity and liabilities
|
387,874
|
285,719
|
Note
|
2015
£m
|
2014
£m
|
|
Cash flows from operating activities5
|
|||
Cash generated from/(used in) continuing operations
|
5,197
|
(87)
|
|
Tax paid
|
(442)
|
(457)
|
|
Net cash from/(used in) operating activities - continuing operations
|
4,755
|
(544)
|
|
Total net cash from/(used in) operating activities
|
4,755
|
(544)
|
|
Cash flows from investing activities
|
|||
Acquisitions of, and additions to, subsidiaries, joint ventures and associates, net of cash acquired
|
7,783
|
(79)
|
|
Disposals of subsidiaries, joint ventures and associates, net of cash transferred
|
(3)
|
110
|
|
New loans to joint ventures and associates
|
(21)
|
(73)
|
|
Repayment of loans to joint ventures and associates
|
-
|
33
|
|
Net new loans to joint ventures and associates
|
(21)
|
(40)
|
|
Purchases of property and equipment
|
(58)
|
(116)
|
|
Proceeds on sale of property and equipment
|
51
|
19
|
|
Other cash flow related to intangible assets
|
(111)
|
(122)
|
|
Net cash from/(used in) investing activities - continuing operations
|
7,641
|
(228)
|
|
Net cash from/(used in) investing activities - discontinued operations1
|
-
|
(20)
|
|
Total net cash from/(used in) from investing activities
|
7,641
|
(248)
|
|
Cash flows from financing activities
|
|||
Redemption of Direct Capital Instrument
|
-
|
(547)
|
|
Proceeds from issue of ordinary shares
|
16
|
8
|
|
Treasury shares purchased for employee trusts
|
(1)
|
-
|
|
New borrowings drawn down, net of expenses
|
2,049
|
2,383
|
|
Repayment of borrowings2
|
(1,979)
|
(2,442)
|
|
Net drawdown/(repayment) of borrowings
|
70
|
(59)
|
|
Interest paid on borrowings
|
(588)
|
(527)
|
|
Preference dividends paid
|
B8
|
(17)
|
(17)
|
Ordinary dividends paid3
|
B8
|
(635)
|
(447)
|
Coupon payments on direct capital instruments and tier 1 notes
|
B8
|
(72)
|
(88)
|
Capital contributions from non-controlling interests of subsidiaries
|
5
|
-
|
|
Dividends paid to non-controlling interests of subsidiaries4
|
(142)
|
(189)
|
|
Changes in controlling interest in subsidiaries
|
(1)
|
(89)
|
|
Net cash used in financing activities - continuing operations
|
(1,365)
|
(1,955)
|
|
Total net cash used in financing activities
|
(1,365)
|
(1,955)
|
|
Total net increase/(decrease) in cash and cash equivalents
|
11,031
|
(2,747)
|
|
Cash and cash equivalents at 1 January
|
22,564
|
25,989
|
|
Effect of exchange rate changes on cash and cash equivalents
|
(425)
|
(678)
|
|
Cash and cash equivalents at 31 December
|
B16
|
33,170
|
22,564
|
1 Discontinued operations represent the results of the US life and related internal asset management businesses (US Life) sold in 2013.
|
2 Includes redemption of 2005 STICS of £268 million.
|
3 Ordinary dividends paid amounted to £635 million (FY14: £449 million. £2 million of unclaimed and waived dividends has been set off against this above).
|
4 Dividends paid to non-controlling interests of subsidiaries included £7 million on the 2003 STICS and £17 million on the 2005 STICS prior to reclassification.
|
5 Cash flows from operating activities include interest received of £5,251 million (FY14: £4,986 million) and dividends received of £2,353 million (FY14: £1,442 million).
|
(i) Amendments to IAS 19, Employee Benefits - Employee Contributions
|
These narrow scope amendments simplify accounting for defined benefit plans that require contributions from employees or third parties. The adoption of the amendments has no impact on the Group's consolidated financial statements as the Group does not have defined benefit plans that require employees or third parties to contribute to the cost of the plan.
|
(ii) Annual Improvements to IFRSs 2011-2013
|
These improvements to IFRSs consist of amendments to four IFRSs including IFRS 3 Business Combinations and IFRS 13 Fair Value Measurement. The amendments clarify existing guidance and there is no impact on the Group's consolidated financial statements.
|
2014
|
|||
As previously reported
£m
|
Effect of change
£m
|
Restated
£m
|
|
Operating profit before tax attributable to shareholders' profits
|
2,173
|
40
|
2,213
|
Non-operating items before tax
|
108
|
(40)
|
68
|
Profit before tax attributable to shareholders' profits
|
2,281
|
-
|
2,281
|
Tax on operating profit
|
(561)
|
(2)
|
(563)
|
Tax on other activities
|
(40)
|
2
|
(38)
|
(601)
|
-
|
(601)
|
|
Profit after tax
|
1,680
|
-
|
1,680
|
Operating profit per share (p)
|
47.0
|
1.3
|
48.3
|
Diluted operating profit per share (p)
|
46.3
|
1.3
|
47.6
|
2015
|
2014
|
|
Eurozone
|
||
Average rate (€1 equals)
|
£0.72
|
£0.81
|
Year end rate (€1 equals)
|
£0.74
|
£0.78
|
Canada
|
||
Average rate ($CAD1 equals)
|
£0.51
|
£0.55
|
Year end rate ($CAD1 equals)
|
£0.49
|
£0.55
|
Poland
|
||
Average rate (PLN1 equals)
|
£0.17
|
£0.19
|
Year end rate (PLN1 equals)
|
£0.17
|
£0.18
|
Book Value £m
|
Fair Value and Accounting Policy Adjustments
£m
|
Fair Value
£m
|
|
Assets
|
|||
Acquired value of in-force business and intangible assets
|
3,055
|
2,219
|
5,274
|
Investment property
|
2,685
|
-
|
2,685
|
Financial investments
|
97,580
|
(11,314)
|
86,266
|
Reinsurance assets
|
1,254
|
11,251
|
12,505
|
Deferred tax assets
|
51
|
54
|
105
|
Other assets
|
2,619
|
(854)
|
1,765
|
Cash and cash equivalents
|
7,878
|
-
|
7,878
|
Total assets
|
115,122
|
1,356
|
116,478
|
Liabilities
|
|||
Insurance liabilities
|
36,068
|
12
|
36,080
|
Liability for investment contracts
|
68,778
|
(129)
|
68,649
|
Unallocated divisible surplus
|
724
|
-
|
724
|
Net asset value attributable to unitholders
|
212
|
-
|
212
|
Deferred tax liabilities
|
1,203
|
240
|
1,443
|
Borrowings
|
1,064
|
243
|
1,307
|
Other liabilities
|
2,355
|
668
|
3,023
|
Total liabilities
|
110,404
|
1,034
|
111,438
|
Net assets
|
4,718
|
322
|
5,040
|
Non-controlling interests (NCI) including tier 1 notes
|
329
|
175
|
504
|
Net assets excluding NCI
|
4,389
|
147
|
4,536
|
Goodwill arising on acquisition
|
671
|
||
Fair value of shares exchanged for net assets
|
5,207
|
||
Fair value of Group liabilities related to pre-existing relationship
|
768
|
||
Fair value of total shares exchanged1
|
5,975
|
1 Fair value of consideration based on the opening market price on the date of acquisition.
|
2015
£m
|
2014
£m
|
|
Spain - long-term business
|
-
|
132
|
Italy - long-term business
|
-
|
(6)
|
Korea
|
-
|
2
|
Turkey - general insurance
|
-
|
(16)
|
Aviva Investors
|
-
|
35
|
Turkey - long-term business
|
1
|
15
|
Indonesia
|
-
|
(3)
|
Other small operations
|
1
|
15
|
Profit on disposal and remeasurement from continuing operations
|
2
|
174
|
Profit on disposal and remeasurement from discontinued operations
|
-
|
58
|
Total profit on disposal and remeasurement
|
2
|
232
|
2015
£m
|
2014
£m
|
|
Assets
|
||
Cash and cash equivalents
|
-
|
9
|
Total assets
|
-
|
9
|
Liabilities
|
||
Insurance liabilities
|
-
|
(1)
|
Other liabilities
|
-
|
(1)
|
Total liabilities
|
-
|
(2)
|
Net assets
|
-
|
7
|
(i) profit or loss from operations before tax attributable to shareholders
|
(ii) profit or loss from operations before tax attributable to shareholders, adjusted for non-operating items outside the segment management's control, including investment market performance and fiscal policy changes.
|
Page 51
|
United Kingdom & Ireland
|
Europe
|
|||||||||
Life
£m
|
GI
£m
|
France
£m
|
Poland
£m
|
Italy, Spain and Other
£m
|
Canada
£m
|
Asia
£m
|
Aviva
Investors2
£m
|
Other Group
activities3
£m
|
Total
£m
|
|
Gross written premiums
|
5,402
|
4,503
|
5,777
|
484
|
2,733
|
2,109
|
917
|
-
|
-
|
21,925
|
Premiums ceded to reinsurers
|
(1,355)
|
(1,163)
|
(75)
|
(6)
|
(42)
|
(117)
|
(132)
|
-
|
-
|
(2,890)
|
Internal reinsurance revenue
|
(5)
|
(1)
|
-
|
(1)
|
(4)
|
-
|
(2)
|
-
|
13
|
-
|
Premiums written net of reinsurance
|
4,042
|
3,339
|
5,702
|
477
|
2,687
|
1,992
|
783
|
-
|
13
|
19,035
|
Net change in provision for unearned premiums
|
(1)
|
(53)
|
(11)
|
(13)
|
(7)
|
(15)
|
(14)
|
-
|
3
|
(111)
|
Net earned premiums
|
4,041
|
3,286
|
5,691
|
464
|
2,680
|
1,977
|
769
|
-
|
16
|
18,924
|
Fee and commission income
|
810
|
160
|
232
|
40
|
115
|
28
|
134
|
281
|
(3)
|
1,797
|
4,851
|
3,446
|
5,923
|
504
|
2,795
|
2,005
|
903
|
281
|
13
|
20,721
|
|
Net investment income/(expense)
|
448
|
159
|
1,949
|
(1)
|
444
|
49
|
(325)
|
155
|
(53)
|
2,825
|
Inter-segment revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
195
|
-
|
195
|
Share of profit of joint ventures and associates
|
149
|
-
|
7
|
5
|
8
|
-
|
11
|
-
|
-
|
180
|
Profit/(loss) on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
2
|
-
|
-
|
-
|
(1)
|
-
|
1
|
-
|
-
|
2
|
Segmental income1
|
5,450
|
3,605
|
7,879
|
508
|
3,246
|
2,054
|
590
|
631
|
(40)
|
23,923
|
Claims and benefits paid, net of recoveries from reinsurers
|
(10,663)
|
(2,533)
|
(4,454)
|
(302)
|
(2,343)
|
(1,240)
|
(415)
|
-
|
(35)
|
(21,985)
|
Change in insurance liabilities, net of reinsurance
|
7,070
|
492
|
(1,093)
|
17
|
264
|
(12)
|
(68)
|
-
|
11
|
6,681
|
Change in investment contract provisions
|
943
|
-
|
(1,915)
|
18
|
(702)
|
-
|
328
|
(159)
|
-
|
(1,487)
|
Change in unallocated divisible surplus
|
22
|
-
|
841
|
12
|
93
|
-
|
16
|
-
|
-
|
984
|
Fee and commission expense
|
(585)
|
(1,195)
|
(623)
|
(57)
|
(252)
|
(571)
|
(114)
|
(26)
|
76
|
(3,347)
|
Other expenses
|
(1,369)
|
(223)
|
(205)
|
(51)
|
(111)
|
(81)
|
(250)
|
(365)
|
(129)
|
(2,784)
|
Inter-segment expenses
|
(169)
|
(5)
|
(9)
|
(6)
|
-
|
(4)
|
-
|
-
|
(2)
|
(195)
|
Finance costs
|
(214)
|
(1)
|
(1)
|
-
|
(4)
|
(4)
|
(3)
|
-
|
(391)
|
(618)
|
Segmental expenses
|
(4,965)
|
(3,465)
|
(7,459)
|
(369)
|
(3,055)
|
(1,912)
|
(506)
|
(550)
|
(470)
|
(22,751)
|
Profit/(loss) before tax from continuing operations
|
485
|
140
|
420
|
139
|
191
|
142
|
84
|
81
|
(510)
|
1,172
|
Tax attributable to policyholders' returns
|
232
|
-
|
-
|
-
|
-
|
-
|
(14)
|
-
|
-
|
218
|
Profit/(loss) before tax attributable to shareholders' profits from continuing operations
|
717
|
140
|
420
|
139
|
191
|
142
|
70
|
81
|
(510)
|
1,390
|
Profit from discontinued operations
|
-
|
-
|
||||||||
Adjusted for non-operating items:
|
||||||||||
Reclassification of corporate costs and unallocated interest
|
7
|
(1)
|
20
|
-
|
-
|
6
|
-
|
4
|
(36)
|
-
|
Investment return variances and economic assumption changes on long-term business
|
-
|
-
|
(17)
|
-
|
14
|
-
|
(11)
|
-
|
-
|
(14)
|
Short-term fluctuation in return on investments backing non-long-term business
|
53
|
84
|
2
|
(2)
|
31
|
47
|
-
|
-
|
(131)
|
84
|
Economic assumption changes on general insurance and health business
|
-
|
98
|
-
|
-
|
-
|
2
|
-
|
-
|
-
|
100
|
Impairment of goodwill, joint ventures and associates and other amounts expensed
|
-
|
-
|
-
|
-
|
9
|
-
|
13
|
-
|
-
|
22
|
Amortisation and impairment of intangibles
|
84
|
14
|
-
|
2
|
14
|
10
|
9
|
10
|
12
|
155
|
Amortisation and impairment of AVIF
|
350
|
-
|
5
|
2
|
5
|
-
|
136
|
-
|
-
|
498
|
(Profit)/loss on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
(2)
|
-
|
-
|
-
|
1
|
-
|
(1)
|
-
|
-
|
(2)
|
Integration and restructuring costs
|
215
|
26
|
19
|
-
|
3
|
7
|
7
|
11
|
91
|
379
|
Adjusted for non-operating items from discontinued operations
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Other4
|
-
|
53
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
53
|
Operating profit/(loss) before tax attributable to shareholders
|
1,424
|
414
|
449
|
141
|
268
|
214
|
223
|
106
|
(574)
|
2,665
|
1 Total reported income, excluding inter-segment revenue, includes £9,031 million from the United Kingdom (Aviva plc's country of domicile). Income is attributed on the basis of geographical origin which does not differ materially from revenue by geographical destination, as most risks are located in the countries where the contracts were written.
|
2 Aviva Investors operating profit includes £1 million profit relating to the Aviva Investors Pooled Pensions business.
|
3 Other Group activities include Group Reinsurance.
|
4 Other items represents a day one loss upon the completion of an outwards reinsurance contract by the UK General Insurance business, which provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks. The £53 million loss comprises £712 million in premiums ceded less £659 million in reinsurance recoverables recognised.
|
|
|
United Kingdom &
Ireland
|
Europe
|
|||||||||
Life
£m
|
GI
£m
|
France
£m
|
Poland
£m
|
Italy, Spain and Other
£m
|
Canada
£m
|
Asia
£m
|
Aviva
Investors2
£m
|
Other Group
activities3
£m
|
Total
£m
|
|
Gross written premiums
|
4,306
|
4,484
|
5,756
|
490
|
3,514
|
2,176
|
942
|
-
|
2
|
21,670
|
Premiums ceded to reinsurers
|
(784)
|
(454)
|
(70)
|
(7)
|
(68)
|
(70)
|
(161)
|
-
|
-
|
(1,614)
|
Internal reinsurance revenue
|
(7)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
-
|
-
|
16
|
-
|
Premiums written net of reinsurance
|
3,515
|
4,028
|
5,684
|
482
|
3,444
|
2,104
|
781
|
-
|
18
|
20,056
|
Net change in provision for unearned premiums
|
23
|
43
|
(27)
|
6
|
10
|
(54)
|
(3)
|
-
|
3
|
1
|
Net earned premiums
|
3,538
|
4,071
|
5,657
|
488
|
3,454
|
2,050
|
778
|
-
|
21
|
20,057
|
Fee and commission income
|
398
|
160
|
203
|
87
|
115
|
15
|
9
|
243
|
-
|
1,230
|
3,936
|
4,231
|
5,860
|
575
|
3,569
|
2,065
|
787
|
243
|
21
|
21,287
|
|
Net investment income/(expense)
|
13,301
|
362
|
5,174
|
147
|
2,392
|
180
|
125
|
267
|
(59)
|
21,889
|
Inter-segment revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
158
|
-
|
158
|
Share of profit/(loss) of joint ventures and associates
|
139
|
-
|
7
|
4
|
9
|
-
|
(12)
|
-
|
-
|
147
|
Profit/(loss) on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
-
|
-
|
-
|
-
|
125
|
14
|
(1)
|
35
|
1
|
174
|
Segmental income1
|
17,376
|
4,593
|
11,041
|
726
|
6,095
|
2,259
|
899
|
703
|
(37)
|
43,655
|
Claims and benefits paid, net of recoveries from reinsurers
|
(7,522)
|
(2,745)
|
(4,594)
|
(331)
|
(2,572)
|
(1,276)
|
(362)
|
-
|
(72)
|
(19,474)
|
Change in insurance liabilities, net of reinsurance
|
(3,955)
|
88
|
(1,119)
|
(70)
|
(212)
|
(70)
|
(294)
|
-
|
62
|
(5,570)
|
Change in investment contract provisions
|
(3,036)
|
-
|
(1,881)
|
8
|
(1,347)
|
-
|
-
|
(262)
|
-
|
(6,518)
|
Change in unallocated divisible surplus
|
(62)
|
-
|
(2,182)
|
(6)
|
(1,055)
|
-
|
(59)
|
-
|
-
|
(3,364)
|
Fee and commission expense
|
(462)
|
(1,294)
|
(564)
|
(65)
|
(289)
|
(570)
|
(60)
|
(24)
|
(61)
|
(3,389)
|
Other expenses
|
(674)
|
(228)
|
(232)
|
(59)
|
(127)
|
(81)
|
(61)
|
(332)
|
(185)
|
(1,979)
|
Inter-segment expenses
|
(137)
|
(4)
|
(4)
|
(7)
|
-
|
(4)
|
-
|
-
|
(2)
|
(158)
|
Finance costs
|
(191)
|
(4)
|
(3)
|
-
|
(4)
|
(5)
|
-
|
(2)
|
(331)
|
(540)
|
Segmental expenses
|
(16,039)
|
(4,187)
|
(10,579)
|
(530)
|
(5,606)
|
(2,006)
|
(836)
|
(620)
|
(589)
|
(40,992)
|
Profit/(loss) before tax from continuing operations
|
1,337
|
406
|
462
|
196
|
489
|
253
|
63
|
83
|
(626)
|
2,663
|
Tax attributable to policyholders' returns
|
(357)
|
-
|
-
|
-
|
-
|
-
|
(25)
|
-
|
-
|
(382)
|
Profit/(loss) before tax attributable to shareholders' profits from continuing operations
|
980
|
406
|
462
|
196
|
489
|
253
|
38
|
83
|
(626)
|
2,281
|
Profit from discontinued operations4
|
58
|
58
|
||||||||
Adjusted for non-operating items:
|
||||||||||
Reclassification of corporate costs and unallocated interest
|
-
|
11
|
16
|
-
|
1
|
-
|
-
|
-
|
(28)
|
-
|
Investment return variances and economic assumption changes on long-term business
|
13
|
-
|
9
|
(4)
|
(101)
|
-
|
11
|
-
|
-
|
(72)
|
Short-term fluctuation in return on investments backing non-long-term business
|
-
|
(82)
|
(50)
|
(1)
|
13
|
(65)
|
-
|
-
|
(76)
|
(261)
|
Economic assumption changes on general insurance and health business
|
-
|
145
|
-
|
-
|
-
|
3
|
-
|
-
|
(3)
|
145
|
Impairment of goodwill, joint ventures and associates and other amounts expensed
|
-
|
-
|
-
|
-
|
-
|
-
|
24
|
-
|
-
|
24
|
Amortisation and impairment of intangibles
|
31
|
1
|
-
|
-
|
17
|
10
|
3
|
11
|
17
|
90
|
Amortisation and impairment of AVIF5
|
10
|
-
|
18
|
3
|
9
|
-
|
-
|
-
|
-
|
40
|
(Profit)/loss on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
-
|
-
|
-
|
-
|
(125)
|
(14)
|
1
|
(35)
|
(1)
|
(174)
|
Integration and restructuring costs
|
28
|
11
|
15
|
1
|
1
|
4
|
1
|
4
|
75
|
140
|
Adjusted for non-operating items from discontinued operations4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(58)
|
(58)
|
Operating profit/(loss) before tax attributable to shareholders5
|
1,062
|
492
|
470
|
195
|
304
|
191
|
78
|
63
|
(642)
|
2,213
|
1 Total reported income, excluding inter-segment revenue, includes £20,816 million from the United Kingdom (Aviva plc's country of domicile). Income is attributed on the basis of geographical origin which does not differ materially from revenue by geographical destination, as most risks are located in the countries where the contracts were written.
|
2 Aviva Investors operating profit includes £2 million profit relating to Aviva Investors Pooled Pensions business.
|
3 Other Group activities include Group Reinsurance.
|
4 In 2014 the Group paid a settlement of £200 million related to the purchase price adjustment relating to the disposal of the US Life business in 2013. The settlement and the aggregate development of other provisions related to the discontinued operations in 2014 resulted in a net £58 million gain which has been presented as profit on disposal of discontinued operations.
|
5 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
United Kingdom & Ireland
|
Europe
|
|||||||||
Life
£m
|
GI
£m
|
France
£m
|
Poland
£m
|
Italy, Spain and Other
£m
|
Canada
£m
|
Asia
£m
|
Aviva Investors
£m
|
Other Group activities
£m
|
Total
£m
|
|
Goodwill
|
663
|
1,026
|
5
|
23
|
172
|
21
|
45
|
-
|
-
|
1,955
|
Acquired value of in-force business and intangible assets
|
3,600
|
139
|
86
|
12
|
539
|
69
|
1,206
|
15
|
65
|
5,731
|
Interests in, and loans to, joint ventures and associates
|
1,291
|
-
|
138
|
39
|
72
|
7
|
372
|
-
|
-
|
1,919
|
Property and equipment
|
130
|
27
|
225
|
3
|
5
|
10
|
8
|
1
|
40
|
449
|
Investment property
|
7,483
|
198
|
2,089
|
-
|
1
|
-
|
-
|
1,146
|
384
|
11,301
|
Loans
|
21,502
|
5
|
733
|
1
|
26
|
135
|
31
|
-
|
-
|
22,433
|
Financial investments
|
163,987
|
4,715
|
65,413
|
2,575
|
19,176
|
3,187
|
9,684
|
515
|
4,965
|
274,217
|
Deferred acquisition costs
|
1,394
|
418
|
227
|
32
|
77
|
255
|
57
|
4
|
-
|
2,464
|
Other assets
|
42,636
|
5,301
|
9,678
|
239
|
1,480
|
860
|
1,351
|
901
|
4,959
|
67,405
|
Assets of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total assets
|
242,686
|
11,829
|
78,594
|
2,924
|
21,548
|
4,544
|
12,754
|
2,582
|
10,413
|
387,874
|
Insurance liabilities
|
||||||||||
Long-term business and outstanding claims provisions
|
99,435
|
5,439
|
16,487
|
2,308
|
7,699
|
2,058
|
2,865
|
-
|
18
|
136,309
|
Unearned premiums
|
226
|
2,083
|
393
|
45
|
237
|
1,016
|
48
|
-
|
-
|
4,048
|
Other insurance liabilities
|
-
|
76
|
44
|
-
|
-
|
77
|
-
|
-
|
2
|
199
|
Liability for investment contracts
|
114,143
|
-
|
47,834
|
2
|
9,770
|
-
|
7,681
|
1,743
|
-
|
181,173
|
Unallocated divisible surplus
|
2,575
|
-
|
4,941
|
55
|
1,047
|
-
|
193
|
-
|
-
|
8,811
|
Net asset value attributable to unitholders
|
203
|
-
|
2,863
|
-
|
413
|
-
|
-
|
-
|
7,936
|
11,415
|
External borrowings
|
1,903
|
-
|
-
|
-
|
49
|
-
|
-
|
-
|
6,818
|
8,770
|
Other liabilities, including inter-segment liabilities
|
12,261
|
(1,240)
|
4,066
|
99
|
715
|
596
|
565
|
370
|
1,485
|
18,917
|
Liabilities of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total liabilities
|
230,746
|
6,358
|
76,628
|
2,509
|
19,930
|
3,747
|
11,352
|
2,113
|
16,259
|
369,642
|
Total equity
|
18,232
|
|||||||||
Total equity and liabilities
|
387,874
|
United Kingdom &
Ireland
|
Europe
|
|||||||||
Life
£m
|
GI
£m
|
France
£m
|
Poland
£m
|
Italy, Spain and Other
£m
|
Canada
£m
|
Asia
£m
|
Aviva Investors
£m
|
Other
Group activities
£m
|
Total
£m
|
|
Goodwill
|
-
|
1,031
|
-
|
8
|
190
|
23
|
50
|
-
|
-
|
1,302
|
Acquired value of in-force business and intangible assets
|
127
|
103
|
96
|
5
|
581
|
60
|
2
|
25
|
29
|
1,028
|
Interests in, and loans to, joint ventures and associates
|
953
|
-
|
145
|
10
|
82
|
2
|
352
|
-
|
-
|
1,544
|
Property and equipment
|
74
|
33
|
214
|
3
|
6
|
9
|
4
|
1
|
13
|
357
|
Investment property
|
5,558
|
95
|
1,758
|
-
|
1
|
-
|
-
|
1,120
|
393
|
8,925
|
Loans
|
24,178
|
84
|
788
|
-
|
58
|
122
|
30
|
-
|
-
|
25,260
|
Financial investments
|
97,410
|
5,415
|
66,484
|
2,829
|
19,959
|
3,483
|
3,192
|
660
|
3,206
|
202,638
|
Deferred acquisition costs
|
1,310
|
438
|
227
|
23
|
89
|
280
|
4
|
7
|
-
|
2,378
|
Other assets
|
19,092
|
4,895
|
10,009
|
171
|
1,585
|
937
|
459
|
784
|
4,346
|
42,278
|
Assets of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
9
|
9
|
Total assets
|
148,702
|
12,094
|
79,721
|
3,049
|
22,551
|
4,916
|
4,093
|
2,597
|
7,996
|
285,719
|
Insurance liabilities
|
||||||||||
Long-term business and outstanding claims provisions
|
71,619
|
5,515
|
16,179
|
2,444
|
8,414
|
2,317
|
2,598
|
-
|
36
|
109,122
|
Unearned premiums
|
225
|
2,038
|
402
|
34
|
247
|
1,114
|
46
|
-
|
1
|
4,107
|
Other insurance liabilities
|
-
|
79
|
46
|
-
|
-
|
89
|
-
|
-
|
2
|
216
|
Liability for investment contracts
|
57,201
|
-
|
48,316
|
10
|
9,867
|
-
|
-
|
1,851
|
-
|
117,245
|
Unallocated divisible surplus
|
1,879
|
-
|
6,104
|
71
|
1,202
|
-
|
211
|
-
|
-
|
9,467
|
Net asset value attributable to unitholders
|
19
|
-
|
2,928
|
-
|
317
|
-
|
-
|
-
|
6,218
|
9,482
|
External borrowings
|
2,016
|
-
|
-
|
-
|
52
|
-
|
-
|
-
|
5,310
|
7,378
|
Other liabilities, including inter-segment liabilities
|
9,539
|
(1,787)
|
3,673
|
120
|
662
|
404
|
388
|
377
|
3,048
|
16,424
|
Liabilities of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
2
|
Total liabilities
|
142,498
|
5,845
|
77,648
|
2,679
|
20,761
|
3,924
|
3,243
|
2,228
|
14,617
|
273,443
|
Total equity
|
12,276
|
|||||||||
Total equity and liabilities
|
285,719
|
Long-term business
£m
|
General insurance
and health2
£m
|
Fund management
£m
|
Other
£m
|
Total
£m
|
|
Gross written premiums1
|
13,187
|
8,738
|
-
|
-
|
21,925
|
Premiums ceded to reinsurers
|
(1,529)
|
(1,361)
|
-
|
-
|
(2,890)
|
Premiums written net of reinsurance
|
11,658
|
7,377
|
-
|
-
|
19,035
|
Net change in provision for unearned premiums
|
-
|
(111)
|
-
|
-
|
(111)
|
Net earned premiums
|
11,658
|
7,266
|
-
|
-
|
18,924
|
Fee and commission income
|
1,161
|
61
|
274
|
301
|
1,797
|
12,819
|
7,327
|
274
|
301
|
20,721
|
|
Net investment income/(expense)
|
2,667
|
240
|
(5)
|
(77)
|
2,825
|
Inter-segment revenue
|
-
|
-
|
201
|
-
|
201
|
Share of profit of joint ventures and associates
|
177
|
3
|
-
|
-
|
180
|
Profit/(loss) on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
1
|
1
|
-
|
-
|
2
|
Segmental income
|
15,664
|
7,571
|
470
|
224
|
23,929
|
Claims and benefits paid, net of recoveries from reinsurers
|
(16,809)
|
(5,176)
|
-
|
-
|
(21,985)
|
Change in insurance liabilities, net of reinsurance
|
6,205
|
476
|
-
|
-
|
6,681
|
Change in investment contract provisions
|
(1,487)
|
-
|
-
|
-
|
(1,487)
|
Change in unallocated divisible surplus
|
984
|
-
|
-
|
-
|
984
|
Fee and commission expense
|
(1,121)
|
(2,118)
|
(23)
|
(85)
|
(3,347)
|
Other expenses
|
(1,663)
|
(368)
|
(367)
|
(386)
|
(2,784)
|
Inter-segment expenses
|
(190)
|
(11)
|
-
|
-
|
(201)
|
Finance costs
|
(202)
|
(5)
|
-
|
(411)
|
(618)
|
Segmental expenses
|
(14,283)
|
(7,202)
|
(390)
|
(882)
|
(22,757)
|
Profit/(loss) before tax from continuing operations
|
1,381
|
369
|
80
|
(658)
|
1,172
|
Tax attributable to policyholder returns
|
218
|
-
|
-
|
-
|
218
|
Profit/(loss) before tax attributable to shareholders' profits
|
1,599
|
369
|
80
|
(658)
|
1,390
|
Adjusted for:
|
|||||
Non-operating items from continuing operations
|
820
|
396
|
26
|
33
|
1,275
|
Operating profit/(loss) before tax attributable to shareholders' profits from continuing operations
|
2,419
|
765
|
106
|
(625)
|
2,665
|
Operating profit/(loss) before tax attributable to shareholders' profits
|
2,419
|
765
|
106
|
(625)
|
2,665
|
1 Gross written premiums include inward reinsurance premiums assumed from other companies amounting to £146 million, of which £80 million relates to property and liability insurance and £66 million relates to long-term business.
|
2 General insurance and health business segment includes gross written premiums of £1,092 million relating to health business. The remaining business relates to property and liability insurance.
|
Long-term business
£m
|
General insurance
and health2
£m
|
Fund management
£m
|
Other
£m
|
Total
£m
|
|
Gross written premiums1
|
12,727
|
8,943
|
-
|
-
|
21,670
|
Premiums ceded to reinsurers
|
(971)
|
(643)
|
-
|
-
|
(1,614)
|
Premiums written net of reinsurance
|
11,756
|
8,300
|
-
|
-
|
20,056
|
Net change in provision for unearned premiums
|
-
|
1
|
-
|
-
|
1
|
Net earned premiums
|
11,756
|
8,301
|
-
|
-
|
20,057
|
Fee and commission income
|
705
|
54
|
256
|
215
|
1,230
|
12,461
|
8,355
|
256
|
215
|
21,287
|
|
Net investment income/(expense)
|
21,295
|
666
|
5
|
(77)
|
21,889
|
Inter-segment revenue
|
-
|
-
|
158
|
-
|
158
|
Share of profit of joint ventures and associates
|
144
|
3
|
-
|
-
|
147
|
Profit/(loss) on the disposal and remeasurement of subsidiaries, joint ventures and associates
|
140
|
(16)
|
35
|
15
|
174
|
Segmental income
|
34,040
|
9,008
|
454
|
153
|
43,655
|
Claims and benefits paid, net of recoveries from reinsurers
|
(13,861)
|
(5,613)
|
-
|
-
|
(19,474)
|
Change in insurance liabilities, net of reinsurance
|
(5,604)
|
34
|
-
|
-
|
(5,570)
|
Change in investment contract provisions
|
(6,518)
|
-
|
-
|
-
|
(6,518)
|
Change in unallocated divisible surplus
|
(3,364)
|
-
|
-
|
-
|
(3,364)
|
Fee and commission expense
|
(977)
|
(2,247)
|
(26)
|
(139)
|
(3,389)
|
Other expenses
|
(920)
|
(402)
|
(321)
|
(336)
|
(1,979)
|
Inter-segment expenses
|
(148)
|
(10)
|
-
|
-
|
(158)
|
Finance costs
|
(191)
|
(11)
|
(2)
|
(336)
|
(540)
|
Segmental expenses
|
(31,583)
|
(8,249)
|
(349)
|
(811)
|
(40,992)
|
Profit/(loss) before tax from continuing operations
|
2,457
|
759
|
105
|
(658)
|
2,663
|
Tax attributable to policyholder returns
|
(382)
|
-
|
-
|
-
|
(382)
|
Profit/(loss) before tax attributable to shareholders' profits
|
2,075
|
759
|
105
|
(658)
|
2,281
|
Adjusted for:
|
|||||
Non-operating items from continuing operations3
|
(56)
|
49
|
(19)
|
(42)
|
(68)
|
Operating profit/(loss) before tax attributable to shareholders' profits from continuing operations3
|
2,019
|
808
|
86
|
(700)
|
2,213
|
Operating profit/(loss) before tax attributable to shareholders' profits3
|
2,019
|
808
|
86
|
(700)
|
2,213
|
1 Gross written premiums include inward reinsurance premiums assumed from other companies amounting to £164 million, of which £81 million relates to property and liability insurance and £83 million relates to long-term business.
|
2 General insurance and health business segment includes gross written premiums of £1,146 million relating to health business. The remaining business relates to property and liability insurance.
|
3 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
|
.
|
Long-term business
£m
|
General insurance and health
£m
|
Fund management
£m
|
Other
£m
|
Total
£m
|
|
Goodwill
|
862
|
1,035
|
-
|
58
|
1,955
|
Acquired value of in-force business and intangible assets
|
5,369
|
309
|
15
|
38
|
5,731
|
Interests in, and loans to, joint ventures and associates
|
1,878
|
34
|
-
|
7
|
1,919
|
Property and equipment
|
299
|
95
|
1
|
54
|
449
|
Investment property
|
10,582
|
335
|
-
|
384
|
11,301
|
Loans
|
22,292
|
141
|
-
|
-
|
22,433
|
Financial investments
|
258,995
|
10,280
|
23
|
4,919
|
274,217
|
Deferred acquisition costs
|
1,647
|
812
|
5
|
-
|
2,464
|
Other assets
|
52,844
|
7,315
|
769
|
6,477
|
67,405
|
Assets of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
Total assets
|
354,768
|
20,356
|
813
|
11,937
|
387,874
|
Gross insurance liabilities
|
127,050
|
13,506
|
-
|
-
|
140,556
|
Gross liabilities for investment contracts
|
181,173
|
-
|
-
|
-
|
181,173
|
Unallocated divisible surplus
|
8,811
|
-
|
-
|
-
|
8,811
|
Net asset value attributable to unitholders
|
3,479
|
-
|
-
|
7,936
|
11,415
|
External borrowings
|
1,857
|
-
|
-
|
6,913
|
8,770
|
Other liabilities, including inter-segment liabilities
|
15,387
|
(307)
|
346
|
3,491
|
18,917
|
Liabilities of operations classified as held for sale
|
-
|
-
|
-
|
-
|
-
|
Total liabilities
|
337,757
|
13,199
|
346
|
18,340
|
369,642
|
Total equity
|
18,232
|
||||
Total equity and liabilities
|
387,874
|
Long-term business
£m
|
General insurance and health
£m
|
Fund management
£m
|
Other
£m
|
Total
£m
|
|
Goodwill
|
216
|
1,043
|
-
|
43
|
1,302
|
Acquired value of in-force business and intangible assets
|
691
|
270
|
25
|
42
|
1,028
|
Interests in, and loans to, joint ventures and associates
|
1,526
|
16
|
-
|
2
|
1,544
|
Property and equipment
|
230
|
100
|
1
|
26
|
357
|
Investment property
|
8,310
|
223
|
-
|
392
|
8,925
|
Loans
|
25,053
|
207
|
-
|
-
|
25,260
|
Financial investments
|
188,094
|
11,435
|
23
|
3,086
|
202,638
|
Deferred acquisition costs
|
1,519
|
852
|
7
|
-
|
2,378
|
Other assets
|
29,839
|
6,270
|
657
|
5,512
|
42,278
|
Assets of operations classified as held for sale
|
-
|
9
|
-
|
-
|
9
|
Total assets
|
255,478
|
20,425
|
713
|
9,103
|
285,719
|
Gross insurance liabilities
|
99,453
|
13,992
|
-
|
-
|
113,445
|
Gross liabilities for investment contracts
|
117,245
|
-
|
-
|
-
|
117,245
|
Unallocated divisible surplus
|
9,467
|
-
|
-
|
-
|
9,467
|
Net asset value attributable to unitholders
|
3,264
|
-
|
-
|
6,218
|
9,482
|
External borrowings
|
2,068
|
-
|
-
|
5,310
|
7,378
|
Other liabilities, including inter-segment liabilities
|
12,689
|
(952)
|
354
|
4,333
|
16,424
|
Liabilities of operations classified as held for sale
|
-
|
2
|
-
|
-
|
2
|
Total liabilities
|
244,186
|
13,042
|
354
|
15,861
|
273,443
|
Total equity
|
12,276
|
||||
Total equity and liabilities
|
285,719
|
Continuing operations
|
2015
£m
|
2014
£m
|
Current tax
|
||
For the year
|
500
|
680
|
Prior period adjustments
|
(68)
|
12
|
Total current tax
|
432
|
692
|
Deferred tax
|
||
Origination and reversal of temporary differences
|
(227)
|
315
|
Changes in tax rates or tax laws
|
(82)
|
(17)
|
Write back of deferred tax assets
|
(30)
|
(7)
|
Total deferred tax
|
(339)
|
291
|
Total tax charged to income statement
|
93
|
983
|
2015
£m
|
2014
£m
|
|
UK tax
|
(294)
|
462
|
Overseas tax
|
387
|
521
|
93
|
983
|
2015
£m
|
2014
£m
|
|
Long-term business technical provisions and other insurance items
|
517
|
(1,209)
|
Deferred acquisition costs
|
(46)
|
34
|
Unrealised gains/(losses) on investments
|
(847)
|
1,254
|
Pensions and other post-retirement obligations
|
(4)
|
7
|
Unused losses and tax credits
|
34
|
32
|
Subsidiaries, associates and joint ventures
|
4
|
5
|
Intangibles and additional value of in-force long-term business
|
(149)
|
(7)
|
Provisions and other temporary differences
|
152
|
175
|
Total deferred tax (credited)/charged to income statement
|
(339)
|
291
|
2015
£m
|
2014
£m
|
|
Current tax from continuing operations
|
||
In respect of pensions and other post-retirement obligations
|
(44)
|
(77)
|
In respect of foreign exchange movements
|
(7)
|
(12)
|
(51)
|
(89)
|
|
Deferred tax from continuing operations
|
||
In respect of pensions and other post-retirement obligations
|
(49)
|
424
|
In respect of unrealised (losses)/gains on investments
|
(6)
|
21
|
(55)
|
445
|
|
Total tax (credited)/charged to other comprehensive income
|
(106)
|
356
|
Shareholder
£m |
Policyholder
£m |
2015
£m
|
Shareholder
£m |
Policyholder
£m |
2014
£m
|
|
Total profit/(loss) before tax
|
1,390
|
(218)
|
1,172
|
2,339
|
382
|
2,721
|
Tax calculated at standard UK corporation tax rate of 20.25% (FY14: 21.5%)
|
281
|
(44)
|
237
|
503
|
82
|
585
|
Reconciling items
|
||||||
Different basis of tax - policyholders
|
-
|
(174)
|
(174)
|
-
|
302
|
302
|
Adjustment to tax charge in respect of prior periods
|
(46)
|
-
|
(46)
|
(36)
|
-
|
(36)
|
Non-assessable income and items not taxed at the full statutory rate
|
19
|
-
|
19
|
(22)
|
-
|
(22)
|
Non-taxable loss/(profit) on sale of subsidiaries and associates
|
1
|
-
|
1
|
(31)
|
-
|
(31)
|
Disallowable expenses
|
67
|
-
|
67
|
76
|
-
|
76
|
Different local basis of tax on overseas profits
|
126
|
-
|
126
|
138
|
(2)
|
136
|
Change in future local statutory tax rates
|
(82)
|
-
|
(82)
|
(17)
|
-
|
(17)
|
Movement in deferred tax not recognised
|
(52)
|
-
|
(52)
|
3
|
-
|
3
|
Tax effect of profit from joint ventures and associates
|
(6)
|
-
|
(6)
|
(4)
|
-
|
(4)
|
Other
|
3
|
-
|
3
|
(9)
|
-
|
(9)
|
Total tax charged/(credited) to income statement
|
311
|
(218)
|
93
|
601
|
382
|
983
|
2015
£m
|
2014
£m
|
|
Tax attributable to policyholder returns
|
(218)
|
382
|
UK corporation tax at a rate of 20.25% (FY14: 21.5%) in respect of the policyholder tax deduction
|
44
|
(82)
|
Different local basis of tax of overseas profits
|
-
|
2
|
Different basis of tax - policyholders per tax reconciliation
|
(174)
|
302
|
2015
|
Restated1
2014
|
|||||
Continuing operations
|
Operating profit
£m
|
Non-operating items
£m
|
Total
£m
|
Operating
profit1
£m
|
Non-operating
items1
£m
|
Total
£m
|
Profit before tax attributable to shareholders' profits
|
2,665
|
(1,275)
|
1,390
|
2,213
|
68
|
2,281
|
Tax attributable to shareholders' profit
|
(598)
|
287
|
(311)
|
(563)
|
(38)
|
(601)
|
Profit for the year
|
2,067
|
(988)
|
1,079
|
1,650
|
30
|
1,680
|
Amount attributable to non-controlling interests
|
(152)
|
(9)
|
(161)
|
(143)
|
(26)
|
(169)
|
Cumulative preference dividends for the year
|
(17)
|
-
|
(17)
|
(17)
|
-
|
(17)
|
Coupon payments in respect of direct capital instruments (DCI) and tier 1 notes (net of tax)
|
(57)
|
-
|
(57)
|
(69)
|
-
|
(69)
|
Profit/(loss) attributable to ordinary shareholders from continuing operations
|
1,841
|
(997)
|
844
|
1,421
|
4
|
1,425
|
Profit/(loss) attributable to ordinary shareholders from discontinued operations
|
-
|
-
|
-
|
-
|
58
|
58
|
Profit/(loss)attributable to ordinary shareholders
|
1,841
|
(997)
|
844
|
1,421
|
62
|
1,483
|
1 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
2015
|
Restated1
2014
|
|||||
Continuing operations
|
Before tax
£m
|
Net of tax, non-controlling interests, preference dividends
and DCI2
£m
|
Per share
p
|
Before tax
£m
|
Net of tax, non-controlling interests, preference dividends
and DCI2
£m
|
Per share
p
|
Operating profit attributable to ordinary shareholders
|
2,665
|
1,841
|
49.2
|
2,213
|
1,421
|
48.3
|
Non-operating items:
|
||||||
Investment return variances and economic assumption changes on long-term business
|
14
|
(37)
|
(1.0)
|
72
|
4
|
0.1
|
Short-term fluctuation in return on investments backing non-long-term business
|
(84)
|
(62)
|
(1.7)
|
261
|
197
|
6.7
|
Economic assumption changes on general insurance and health business
|
(100)
|
(80)
|
(2.1)
|
(145)
|
(114)
|
(3.9)
|
Impairment of goodwill, joint ventures and associates and other amounts expensed
|
(22)
|
(22)
|
(0.6)
|
(24)
|
(24)
|
(0.8)
|
Amortisation and impairment of intangibles
|
(155)
|
(121)
|
(3.2)
|
(90)
|
(61)
|
(2.1)
|
Amortisation and impairment of acquired value of in-force business1
|
(498)
|
(376)
|
(10.1)
|
(40)
|
(38)
|
(1.3)
|
Profit on disposal and remeasurement of subsidiaries, joint ventures and associates
|
2
|
2
|
0.1
|
174
|
170
|
5.8
|
Integration and restructuring costs and other
|
(432)
|
(301)
|
(8.0)
|
(140)
|
(130)
|
(4.4)
|
Profit attributable to ordinary shareholders from continuing operations
|
1,390
|
844
|
22.6
|
2,281
|
1,425
|
48.4
|
Profit attributable to ordinary shareholders from discontinued operations
|
-
|
-
|
-
|
58
|
58
|
2.0
|
Profit attributable to ordinary shareholders
|
1,390
|
844
|
22.6
|
2,339
|
1,483
|
50.4
|
1 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
2 DCI includes the direct capital instrument and tier 1 notes.
|
2015
|
2014
|
|||||
Total
£m
|
Weighted average number of shares
million
|
Per share
p
|
Total
£m
|
Weighted average number of shares
million
|
Per share
p
|
|
Profit attributable to ordinary shareholders
|
844
|
3,741
|
22.6
|
1,425
|
2,943
|
48.4
|
Dilutive effect of share awards and options
|
-
|
39
|
(0.3)
|
-
|
44
|
(0.7)
|
Diluted earnings per share from continuing operations
|
844
|
3,780
|
22.3
|
1,425
|
2,987
|
47.7
|
Profit attributable to ordinary shareholders
|
-
|
3,741
|
-
|
58
|
2,943
|
2.0
|
Dilutive effect of share awards and options
|
-
|
39
|
-
|
-
|
44
|
(0.1)
|
Diluted earnings per share from discontinued operations
|
-
|
3,780
|
-
|
58
|
2,987
|
1.9
|
Diluted earnings per share
|
844
|
3,780
|
22.3
|
1,483
|
2,987
|
49.6
|
2015
|
Restated1
2014
|
|||||
Total
£m
|
Weighted average number of shares
million
|
Per share
p
|
Total1
£m
|
Weighted average number of shares
million
|
Per share
p
|
|
Operating profit attributable to ordinary shareholders
|
1,841
|
3,741
|
49.2
|
1,421
|
2,943
|
48.3
|
Dilutive effect of share awards and options
|
-
|
39
|
(0.5)
|
-
|
44
|
(0.7)
|
Diluted operating profit per share from continuing operations
|
1,841
|
3,780
|
48.7
|
1,421
|
2,987
|
47.6
|
Operating profit attributable to ordinary shareholders
|
-
|
3,741
|
-
|
-
|
2,943
|
-
|
Dilutive effect of share awards and options
|
-
|
39
|
-
|
-
|
44
|
-
|
Diluted operating profit per share from discontinued operations
|
-
|
3,780
|
-
|
-
|
2,987
|
-
|
Diluted operating profit per share
|
1,841
|
3,780
|
48.7
|
1,421
|
2,987
|
47.6
|
1 Operating profit has been restated to exclude amortisation and impairment of acquired value of in-force business, which is now shown as a non-operating item. See note B2 for further details. There is no impact on the result or the total equity for any period presented as a result of this restatement.
|
2015
£m
|
2014
£m
|
|
Ordinary dividends declared and charged to equity in the year
|
||
Final 2014 - 12.25 pence per share, paid on 15 May 2015
|
362
|
-
|
Final 2013 - 9.40 pence per share, paid on 16 May 2014
|
-
|
277
|
Interim 2015 - 6.75 pence per share, paid on 17 November 2015
|
273
|
-
|
Interim 2014 - 5.85 pence per share, paid on 17 November 2014
|
-
|
172
|
635
|
449
|
|
Dividends waived/unclaimed returned to the Company
|
-
|
(3)
|
Preference dividends declared and charged to equity in the year
|
17
|
17
|
Coupon payments on direct capital instruments and tier 1 notes
|
72
|
88
|
724
|
551
|
2015
|
2014
|
|||||
Long-term
business
£m
|
General insurance and health
£m |
Total
£m
|
Long-term business
£m
|
General insurance and health
£m
|
Total
£m
|
|
Long-term business provisions
|
||||||
Participating
|
53,875
|
-
|
53,875
|
44,834
|
-
|
44,834
|
Unit-linked non-participating
|
14,768
|
-
|
14,768
|
7,963
|
-
|
7,963
|
Other non-participating
|
56,705
|
-
|
56,705
|
45,313
|
-
|
45,313
|
125,348
|
-
|
125,348
|
98,110
|
-
|
98,110
|
|
Outstanding claims provisions
|
1,702
|
7,063
|
8,765
|
1,343
|
7,298
|
8,641
|
Provision for claims incurred but not reported
|
-
|
2,383
|
2,383
|
-
|
2,578
|
2,578
|
1,702
|
9,446
|
11,148
|
1,343
|
9,876
|
11,219
|
|
Provision for unearned premiums
|
-
|
4,048
|
4,048
|
-
|
4,107
|
4,107
|
Provision arising from liability adequacy tests
|
-
|
12
|
12
|
-
|
10
|
10
|
Total
|
127,050
|
13,506
|
140,556
|
99,453
|
13,993
|
113,446
|
Less: Amounts classified as held for sale
|
-
|
-
|
-
|
-
|
(1)
|
(1)
|
127,050
|
13,506
|
140,556
|
99,453
|
13,992
|
113,445
|
2015
|
Gross
£m
|
Reinsurance1
£m
|
Net
£m
|
Long-term business liabilities
|
|||
Change in long-term business provisions (note B9b(iv))
|
(6,640)
|
252
|
(6,388)
|
Change in provision for outstanding claims
|
179
|
4
|
183
|
(6,461)
|
256
|
(6,205)
|
|
General insurance and health liabilities
|
|||
Change in insurance liabilities (note B9c(iv) and B11c(ii))
|
29
|
(504)
|
(475)
|
Less: Unwind of discount on GI reserves and other
|
(10)
|
9
|
(1)
|
19
|
(495)
|
(476)
|
|
Total change in insurance liabilities
|
(6,442)
|
(239)
|
(6,681)
|
1 The change in reinsurance assets for general insurance and health business includes the impact of the £659 million reinsurance asset recognised on completion of an outward reinsurance contract by the UK general insurance business, which provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks.
|
2014
|
Gross
£m
|
Reinsurance
£m |
Net
£m
|
Long-term business liabilities
|
|||
Change in long-term business provisions (note B9b(iv))
|
5,847
|
(376)
|
5,471
|
Change in provision for outstanding claims
|
128
|
4
|
132
|
5,975
|
(372)
|
5,603
|
|
General insurance and health liabilities
|
|||
Change in insurance liabilities (note B9c(iv) and B11c(ii))
|
(76)
|
49
|
(27)
|
Less: Unwind of discount on GI reserves and other
|
(9)
|
3
|
(6)
|
(85)
|
52
|
(33)
|
|
Total change in insurance liabilities
|
5,890
|
(320)
|
5,570
|
· In the UK mainly in:
|
- New With-Profits Sub-Fund (NWPSF) of Aviva Life & Pensions UK (UKLAP), where the with-profit policyholders are entitled to at least 90% of the distributed profits, with the shareholders receiving the balance. Any surplus or deficit emerging in NWPSF that is not distributed as bonus will be transferred from this sub-fund to the
Reattributed Inherited Estate External Support Account (RIEESA) (see below). |
- Old With-Profits Sub-Fund (OWPSF), With-Profits Sub-Fund (WPSF) and Provident Mutual Sub-Fund (PMSF) of UKLAP, where the with-profit policyholders are entitled to at least 90% of the distributed profits, with the shareholders receiving the balance.
|
- 'Non-profit' funds of Aviva Annuity UK, UKLAP, Friends Life Limited and Friends Life and Pensions Limited where shareholders are entitled to 100% of the distributed profits. Shareholder profits on unitised with-profits business written by WPSF and on stakeholder unitised with-profits business are derived from management fees and policy
charges, and emerge in the non-profits funds. |
- The RIEESA of UKLAP, which is a non-profits fund where shareholders are entitled to 100% of the distributed profits, but these cannot be distributed until the 'lock-in' criteria set by the Reattribution Scheme have been met. The RIEESA has been used to write non-profit business and also to provide capital support to NWPSF.
|
- The Friends Provident With-Profits Fund (FP WPF) where shareholders are entitled to 10% of the distributed profits, plus 60% of the surplus arising on pre-demutualisation non-profit and unitised business and non-investment sources of surplus on policies held by post-demutualisation policyholders. The Friends Provident demutualisation occurred
in 2001. |
- The Friends Provident Life Assurance Limited With-Profits Fund (FPLAL WPF), which is closed to new business and where policyholders are entitled to 100% of the distributed profits.
|
- The Friends Life Company Limited New With-Profits Fund (FLC New WPF), the Friends Life Company Limited Old With-Profits Fund (FLC Old WPF), the Friends Life WL Limited (formally known as Winterthur Life UK Limited) With-Profits Fund (WL WPF) and Friends Life Assurance Society With-Profits Fund (FLAS WPF) which are closed to new
business and where policyholders are entitled to 90% of the distributed profits aside from certain policies in the FLC New WPF and the FLC Old WPF with guaranteed bonus rates, where the shareholders do not receive one-ninth of the bonus. |
· In France, the majority of policyholders' benefits are determined by investment performance, subject to certain guarantees, and shareholders' profits are derived largely from management fees. In addition, a substantial number of policies participate in investment returns, with the balance being attributable to shareholders.
|
· In other operations in Europe and Asia, a range of long-term insurance and savings products are written.
|
· Maturity Guarantees;
|
· Guarantees on surrender, including no-MVR (Market Value Reduction) Guarantees and Guarantees linked to inflation;
|
· Guaranteed Annuity Options;
|
· GMP (Guaranteed Minimum Pension) underpin on Section 32 transfers; and
|
· Expected payments under Mortgage Endowment Promise.
|
Volatility
|
2015
|
2014
|
Equity returns
|
22.6%
|
22.3%
|
Property returns
|
16.0%
|
15.0%
|
Fixed interest yields
|
30.6%
|
27.2%
|
Mortality table used
|
2015
|
2014
|
Assurances, pure endowments and deferred annuities before vesting
|
Nil or Axx00 adjusted
|
Nil or Axx00 adjusted
|
Pensions business after vesting and pensions annuities in payment
|
PCMA00/PCFA00 adjusted plus allowance for future mortality improvement
|
PCMA00/PCFA00 adjusted plus allowance for future mortality improvement
|
Valuation discount rates
|
2015
|
2014
|
Assurances
|
||
Life conventional non-profit
|
1.8%
|
1.7%
|
Pensions conventional non-profit
|
2.3%
|
2.1%
|
Annuities
|
||
Conventional immediate and deferred annuities
|
0.9% to 3.6%
|
1.3% to 3.3%
|
Non-unit reserves on Unit Linked business
|
||
Life
|
1.8% to 2.9%
|
1.7%
|
Pensions
|
1.8% to 3.5%
|
2.1%
|
Income Protection
|
||
Active lives
|
2.0%
|
1.8%
|
Claims in payment - level
|
2.0%
|
1.8%
|
Claims in payment - index linked
|
0.0%
|
(0.9)%
|
Mortality tables used
|
2015
|
2014
|
Assurances
|
||
Non-profit
|
AM00/AF00 or TM00/TF00 adjusted for smoker status and age/sex specific factors
|
AM00/AF00 or TM00/TF00 adjusted for smoker status and age/sex specific factors
|
Pure endowments and deferred annuities before vesting
|
AM00/AF00 adjusted
|
AM00/AF00 adjusted
|
Annuities in payment
|
||
Pensions business and general annuity business
|
PCMA00/PCFA00 adjusted plus allowance for future mortality improvement
|
PCMA00/PCFA00 adjusted plus allowance for future mortality improvement
|
Valuation discount rates
|
Mortality tables used
|
|
2015 and 2014
|
2015 and 2014
|
|
TD73-77, TD88-90,TH00-02
|
||
TF00-02, H_AVDBS, F_AVDBS
|
||
Life assurances
|
0% to 4.5%
|
H_SSDBS, F_SSDBS
|
Annuities
|
0% to 4.5%
|
TGF05/TGH05
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
98,110
|
94,972
|
Provisions in respect of new business
|
4,059
|
4,796
|
Expected change in existing business provisions
|
(8,180)
|
(5,806)
|
Variance between actual and expected experience
|
428
|
1,383
|
Impact of operating assumption changes
|
(735)
|
(1,118)
|
Impact of economic assumption changes
|
(2,242)
|
6,819
|
Other movements
|
30
|
(227)
|
Change in liability recognised as an expense (note B9a(ii))
|
(6,640)
|
5,847
|
Effect of portfolio transfers, acquisitions and disposals1,2
|
35,099
|
(805)
|
Foreign exchange rate movements
|
(1,221)
|
(1,904)
|
Carrying amount at 31 December
|
125,348
|
98,110
|
1 The movement during 2015 relates to Friends Life, as at the acquisition date.
|
2 The movement during 2014 includes £103 million related to the disposal of Eurovita, £696 million related to the disposal of CxG and £6 million related to the restructuring of our operations in Indonesia.
|
As at 31 December 2015
|
As at 31 December 2014
|
|||||
Outstanding claim provisions £m
|
IBNR provisions £m
|
Total claim provisions £m
|
Outstanding claim provisions
£m
|
IBNR provisions
£m
|
Total claim provisions
£m
|
|
Motor
|
3,509
|
1,055
|
4,564
|
3,510
|
1,130
|
4,640
|
Property
|
1,339
|
158
|
1,497
|
1,402
|
67
|
1,469
|
Liability
|
1,776
|
1,106
|
2,882
|
1,916
|
1,224
|
3,140
|
Creditor
|
23
|
18
|
41
|
25
|
21
|
46
|
Other
|
416
|
46
|
462
|
445
|
136
|
581
|
7,063
|
2,383
|
9,446
|
7,298
|
2,578
|
9,876
|
Rate
|
Mean term of liabilities
|
|||
Class
|
2015
|
2014
|
2015
|
2014
|
Reinsured London Market business
|
2.0%
|
2.1%
|
9 years
|
10 years
|
Latent claims
|
0.00% to 2.30%
|
0.16% to 2.75%
|
6 to 15 years
|
6 to 15 years
|
Structured settlements
|
2.1%
|
2.0%
|
38 years
|
35 years
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
9,876
|
10,298
|
Impact of changes in assumptions
|
115
|
211
|
Claim losses and expenses incurred in the current year
|
5,889
|
5,950
|
Decrease in estimated claim losses and expenses incurred in prior periods
|
(463)
|
(329)
|
Incurred claims losses and expenses
|
5,541
|
5,832
|
Less:
|
||
Payments made on claims incurred in the current year
|
(3,153)
|
(3,253)
|
Payments made on claims incurred in prior periods
|
(2,650)
|
(2,933)
|
Recoveries on claim payments
|
281
|
269
|
Claims payments made in the period, net of recoveries
|
(5,522)
|
(5,917)
|
Unwind of discounting
|
10
|
9
|
Changes in claims reserve recognised as an expense (note B9a(ii))
|
29
|
(76)
|
Effect of portfolio transfers, acquisitions and disposals
|
(64)
|
(121)
|
Foreign exchange rate movements
|
(395)
|
(222)
|
Other movements
|
-
|
(3)
|
Carrying amount at 31 December
|
9,446
|
9,876
|
· £166 million release from UK & Ireland due to favourable development on personal and commercial motor, commercial liability and commercial property claims.
|
· £109 million release from Canada mainly due to continued favourable experience on motor, following the legislative changes in Ontario.
|
· £52 million release from Europe mainly due to favourable development in France and Italy.
|
· £112 million release from UK & Ireland due to favourable development on personal and commercial motor, and commercial property claims.
|
· £97 million release from Canada mainly due to continued favourable experience on motor, following the legislative changes in Ontario.
|
· £15 million release from Europe mainly due to favourable development in France and Italy, partly offset by strengthening of motor third party claims in Turkey.
|
Accident year
|
All prior years
£m
|
2006
£m
|
2007
£m
|
2008
£m
|
2009
£m
|
2010
£m
|
2011
£m
|
2012
£m
|
2013
£m
|
2014
£m
|
2015
£m
|
Total
£m
|
Gross cumulative claim payments
|
||||||||||||
At end of accident year
|
(3,653)
|
(4,393)
|
(4,915)
|
(3,780)
|
(3,502)
|
(3,420)
|
(3,055)
|
(3,068)
|
(3,102)
|
(2,991)
|
||
One year later
|
(5,525)
|
(6,676)
|
(7,350)
|
(5,464)
|
(5,466)
|
(4,765)
|
(4,373)
|
(4,476)
|
(4,295)
|
|||
Two years later
|
(5,971)
|
(7,191)
|
(7,828)
|
(6,102)
|
(5,875)
|
(5,150)
|
(4,812)
|
(4,916)
|
||||
Three years later
|
(6,272)
|
(7,513)
|
(8,304)
|
(6,393)
|
(6,163)
|
(5,457)
|
(5,118)
|
|||||
Four years later
|
(6,531)
|
(7,836)
|
(8,607)
|
(6,672)
|
(6,405)
|
(5,712)
|
||||||
Five years later
|
(6,736)
|
(8,050)
|
(8,781)
|
(6,836)
|
(6,564)
|
|||||||
Six years later
|
(6,936)
|
(8,144)
|
(8,906)
|
(6,958)
|
||||||||
Seven years later
|
(7,015)
|
(8,224)
|
(8,986)
|
|||||||||
Eight years later
|
(7,062)
|
(8,257)
|
||||||||||
Nine years later
|
(7,077)
|
|||||||||||
Estimate of gross ultimate claims
|
||||||||||||
At end of accident year
|
7,533
|
8,530
|
9,508
|
7,364
|
6,911
|
6,428
|
6,201
|
6,122
|
5,896
|
5,851
|
||
One year later
|
7,318
|
8,468
|
9,322
|
7,297
|
7,006
|
6,330
|
6,028
|
6,039
|
5,833
|
|||
Two years later
|
7,243
|
8,430
|
9,277
|
7,281
|
6,950
|
6,315
|
6,002
|
6,029
|
||||
Three years later
|
7,130
|
8,438
|
9,272
|
7,215
|
6,914
|
6,292
|
5,952
|
|||||
Four years later
|
7,149
|
8,409
|
9,235
|
7,204
|
6,912
|
6,262
|
||||||
Five years later
|
7,167
|
8,446
|
9,252
|
7,239
|
6,906
|
|||||||
Six years later
|
7,167
|
8,381
|
9,213
|
7,217
|
||||||||
Seven years later
|
7,176
|
8,381
|
9,207
|
|||||||||
Eight years later
|
7,184
|
8,378
|
||||||||||
Nine years later
|
7,207
|
|||||||||||
Estimate of gross ultimate claims
|
7,207
|
8,378
|
9,207
|
7,217
|
6,906
|
6,262
|
5,952
|
6,029
|
5,833
|
5,851
|
||
Cumulative payments
|
(7,077)
|
(8,257)
|
(8,986)
|
(6,958)
|
(6,564)
|
(5,712)
|
(5,118)
|
(4,916)
|
(4,295)
|
(2,991)
|
||
2,329
|
130
|
121
|
221
|
259
|
342
|
550
|
834
|
1,113
|
1,538
|
2,860
|
10,297
|
|
Effect of discounting
|
(407)
|
(12)
|
(1)
|
(4)
|
(19)
|
(17)
|
3
|
(6)
|
(2)
|
-
|
-
|
(465)
|
Present value
|
1,922
|
118
|
120
|
217
|
240
|
325
|
553
|
828
|
1,111
|
1,538
|
2,860
|
9,832
|
Cumulative effect of foreign exchange movements
|
-
|
5
|
(1)
|
(28)
|
(32)
|
(47)
|
(65)
|
(76)
|
(77)
|
(76)
|
-
|
(397)
|
Effect of acquisitions
|
7
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11
|
Present value recognised in the statement of financial position
|
1,929
|
127
|
119
|
189
|
208
|
278
|
488
|
752
|
1,034
|
1,462
|
2,860
|
9,446
|
Accident year
|
All prior years
£m
|
2006
£m
|
2007
£m
|
2008
£m
|
2009
£m
|
2010
£m
|
2011
£m
|
2012
£m
|
2013
£m
|
2014
£m
|
2015
£m
|
Total
£m
|
Net cumulative claim payments
|
||||||||||||
At end of accident year
|
(3,612)
|
(4,317)
|
(4,808)
|
(3,650)
|
(3,386)
|
(3,300)
|
(2,925)
|
(2,905)
|
(2,972)
|
(2,867)
|
||
One year later
|
(5,442)
|
(6,542)
|
(7,165)
|
(5,286)
|
(5,242)
|
(4,578)
|
(4,166)
|
(4,240)
|
(4,079)
|
|||
Two years later
|
(5,881)
|
(7,052)
|
(7,638)
|
(5,885)
|
(5,637)
|
(4,963)
|
(4,575)
|
(4,649)
|
||||
Three years later
|
(6,181)
|
(7,356)
|
(8,094)
|
(6,177)
|
(5,905)
|
(5,263)
|
(4,870)
|
|||||
Four years later
|
(6,434)
|
(7,664)
|
(8,356)
|
(6,410)
|
(6,137)
|
(5,485)
|
||||||
Five years later
|
(6,625)
|
(7,852)
|
(8,515)
|
(6,568)
|
(6,278)
|
|||||||
Six years later
|
(6,724)
|
(7,942)
|
(8,626)
|
(6,657)
|
||||||||
Seven years later
|
(6,789)
|
(8,004)
|
(8,682)
|
|||||||||
Eight years later
|
(6,831)
|
(8,033)
|
||||||||||
Nine years later
|
(6,853)
|
|||||||||||
Estimate of net ultimate claims
|
||||||||||||
At end of accident year
|
7,430
|
8,363
|
9,262
|
7,115
|
6,650
|
6,202
|
5,941
|
5,838
|
5,613
|
5,548
|
||
One year later
|
7,197
|
8,302
|
9,104
|
7,067
|
6,751
|
6,103
|
5,765
|
5,745
|
5,575
|
|||
Two years later
|
7,104
|
8,244
|
9,028
|
7,036
|
6,685
|
6,095
|
5,728
|
5,752
|
||||
Three years later
|
6,996
|
8,249
|
9,007
|
6,978
|
6,644
|
6,077
|
5,683
|
|||||
Four years later
|
6,980
|
8,210
|
8,962
|
6,940
|
6,634
|
6,034
|
||||||
Five years later
|
6,992
|
8,221
|
8,949
|
6,977
|
6,614
|
|||||||
Six years later
|
6,939
|
8,149
|
8,926
|
6,908
|
||||||||
Seven years later
|
6,938
|
8,143
|
8,894
|
|||||||||
Eight years later
|
6,947
|
8,133
|
||||||||||
Nine years later
|
6,948
|
|||||||||||
Estimate of net ultimate claims
|
6,948
|
8,133
|
8,894
|
6,908
|
6,614
|
6,034
|
5,683
|
5,752
|
5,575
|
5,548
|
||
Cumulative payments
|
(6,853)
|
(8,033)
|
(8,682)
|
(6,657)
|
(6,278)
|
(5,485)
|
(4,870)
|
(4,649)
|
(4,079)
|
(2,867)
|
||
761
|
95
|
100
|
212
|
251
|
336
|
549
|
813
|
1,103
|
1,496
|
2,681
|
8,397
|
|
Effect of discounting
|
(116)
|
(12)
|
(1)
|
(4)
|
(19)
|
(17)
|
3
|
(6)
|
(2)
|
-
|
-
|
(174)
|
Present value
|
645
|
83
|
99
|
208
|
232
|
319
|
552
|
807
|
1,101
|
1,496
|
2,681
|
8,223
|
Cumulative effect of foreign exchange movements
|
-
|
5
|
(1)
|
(28)
|
(31)
|
(45)
|
(62)
|
(74)
|
(74)
|
(73)
|
-
|
(383)
|
Effect of acquisitions
|
7
|
4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
11
|
Present value recognised in the statement of financial position
|
652
|
92
|
98
|
180
|
201
|
274
|
490
|
733
|
1,027
|
1,423
|
2,681
|
7,851
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
4,107
|
4,226
|
Premiums written during the year
|
8,738
|
8,943
|
Less: Premiums earned during the year
|
(8,613)
|
(8,935)
|
Changes in UPR recognised as an (income)/expense
|
125
|
8
|
Gross portfolio transfers and acquisitions
|
-
|
(31)
|
Foreign exchange rate movements
|
(184)
|
(96)
|
Carrying amount at 31 December
|
4,048
|
4,107
|
2015
£m
|
2014
£m
|
|
Long-term business
|
||
Participating contracts
|
78,048
|
67,232
|
Non-participating contracts at fair value
|
103,125
|
50,013
|
Total
|
181,173
|
117,245
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
67,232
|
70,628
|
Provisions in respect of new business
|
3,710
|
4,144
|
Expected change in existing business provisions
|
(4,219)
|
(1,972)
|
Variance between actual and expected experience
|
1,590
|
713
|
Impact of operating assumption changes
|
43
|
14
|
Impact of economic assumption changes
|
97
|
303
|
Other movements
|
49
|
16
|
Change in liability recognised as an expense
|
1,270
|
3,218
|
Effect of portfolio transfers, acquisitions and disposals1
|
12,245
|
(2,671)
|
Foreign exchange rate movements
|
(2,699)
|
(3,943)
|
Carrying amount at 31 December
|
78,048
|
67,232
|
1 The movement during 2015 relates to Friends Life, as at the acquisition date and the movement during 2014 relates to the disposal of Eurovita.
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
50,013
|
48,140
|
Provisions in respect of new business
|
2,644
|
2,273
|
Expected change in existing business provisions
|
(2,726)
|
(1,442)
|
Variance between actual and expected experience
|
(2,906)
|
1,575
|
Impact of operating assumption changes
|
32
|
2
|
Impact of economic assumption changes
|
3
|
11
|
Other movements
|
38
|
8
|
Change in liability
|
(2,915)
|
2,427
|
Effect of portfolio transfers, acquisitions and disposals1
|
56,401
|
(20)
|
Foreign exchange rate movements
|
(374)
|
(534)
|
Carrying amount at 31 December
|
103,125
|
50,013
|
1 The movement during 2015 relates to Friends Life, as at the acquisition date and the movement during 2014 relates to the disposal of Eurovita.
|
2015
£m1
|
2014
£m
|
|
Long-term business
|
||
Insurance contracts
|
5,018
|
4,032
|
Participating investment contracts
|
11
|
3
|
Non-participating investment contracts2
|
13,967
|
2,533
|
18,996
|
6,568
|
|
Outstanding claims provisions
|
38
|
43
|
19,034
|
6,611
|
|
General insurance and health
|
||
Outstanding claims provisions3
|
988
|
724
|
Provisions for claims incurred but not reported3
|
607
|
373
|
1,595
|
1,097
|
|
Provisions for unearned premiums
|
289
|
250
|
1,884
|
1,347
|
|
Total
|
20,918
|
7,958
|
1 Reinsurance assets at 31 December 2015 for long-term non-participating investment contracts includes £11,927 million for Friends Life business.
|
2 Balances in respect of all reinsurance treaties are included under reinsurance assets, regardless of whether they transfer significant insurance risk. The reinsurance assets classified as non-participating investment contracts are financial instruments measured at fair value through profit or loss.
|
3 Reinsurance assets at 31 December 2015 for General insurance and health business include the impact of the £659 million reinsurance asset recognised on completion of an outward reinsurance contract by the UK general insurance business, which provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks.
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
6,568
|
5,784
|
Assets in respect of new business
|
664
|
316
|
Expected change in existing business assets
|
197
|
7
|
Variance between actual and expected experience
|
(1,007)
|
536
|
Impact of operating assumption changes
|
(351)
|
(585)
|
Impact of economic assumption changes
|
(177)
|
554
|
Other movements1
|
636
|
34
|
Change in assets
|
(38)
|
862
|
Effect of portfolio transfers, acquisitions and disposals2
|
12,504
|
(13)
|
Foreign exchange rate movements
|
(38)
|
(65)
|
Carrying amount at 31 December
|
18,996
|
6,568
|
1 The other movements in 2015 include the reclassification of the UK Life staff pension scheme investments in Blackrock and Schroder life insurance funds from investments to reinsurance assets.
|
2 The movement during 2015 relates to Friends Life as at the acquisition date. The movement during 2014 includes £12 million related to the disposal of Eurovita and £1 million related to the disposal of CxG.
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
1,097
|
1,164
|
Impact of changes in assumptions
|
14
|
65
|
Reinsurers' share of claim losses and expenses
|
||
Incurred in current year
|
301
|
292
|
Incurred in prior years1
|
527
|
(105)
|
Reinsurers' share of incurred claim losses and expenses
|
828
|
187
|
Less:
|
||
Reinsurance recoveries received on claims
|
||
Incurred in current year
|
(121)
|
(131)
|
Incurred in prior years
|
(225)
|
(173)
|
Reinsurance recoveries received in the year
|
(346)
|
(304)
|
Unwind of discounting
|
8
|
3
|
Change in reinsurance asset recognised as income (note B9a(ii))
|
504
|
(49)
|
Effect of portfolio transfers, acquisitions and disposals
|
(4)
|
(31)
|
Foreign exchange rate movements
|
(2)
|
8
|
Other movements
|
-
|
5
|
Carrying amount at 31 December
|
1,595
|
1,097
|
1 The change in reinsurance assets includes the impact of the £659 million reinsurance asset recognised on completion of an outward reinsurance contract by the UK general insurance business, which provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks.
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
250
|
256
|
Premiums ceded to reinsurers in the year1
|
1,360
|
643
|
Less: Reinsurers' share of premiums earned during the year1
|
(1,346)
|
(634)
|
Changes in reinsurance asset recognised as income
|
14
|
9
|
Reinsurers' share of portfolio transfers and acquisitions
|
33
|
(2)
|
Foreign exchange rate movements
|
(8)
|
(10)
|
Other movements
|
-
|
(3)
|
Carrying amount at 31 December
|
289
|
250
|
1 Includes £712 million of premiums ceded on completion of the outward reinsurance contract taken out by the UK general insurance business, which provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks.
|
Effect on profit
2015
£m
|
Effect on profit
2014
£m
|
|
Assumptions
|
||
Long-term insurance business
|
||
Interest rates
|
2,053
|
(4,578)
|
Expenses
|
248
|
75
|
Persistency rates
|
(2)
|
15
|
Mortality for assurance contracts
|
1
|
20
|
Mortality for annuity contracts
|
17
|
283
|
Tax and other assumptions
|
48
|
75
|
Investment contracts
|
||
Interest rates
|
-
|
(2)
|
Expenses
|
(4)
|
-
|
General insurance and health business
|
||
Change in discount rate assumptions
|
(100)
|
(145)
|
Change in expense ratio and other assumptions
|
1
|
1
|
Total
|
2,262
|
(4,256)
|
2015
£m
|
2014
£m
|
|
Carrying amount at 1 January
|
9,467
|
6,709
|
Change in participating contract assets
|
(935)
|
3,087
|
Change in participating contract liabilities
|
(36)
|
299
|
Other movements
|
(13)
|
(22)
|
Change in liability recognised as an expense
|
(984)
|
3,364
|
Effect of portfolio transfers, acquisition and disposals
|
724
|
(131)
|
Foreign exchange rate movements
|
(396)
|
(444)
|
Other movements
|
-
|
(31)
|
8,811
|
9,467
|
2015
£m
|
2014
£m
|
|
Core structural borrowings, at amortised cost
|
6,912
|
5,310
|
Operational borrowings, at amortised cost
|
550
|
696
|
Operational borrowings, at fair value
|
1,308
|
1,372
|
1,858
|
2,068
|
|
8,770
|
7,378
|
2015
|
2014
|
|||||
Core Structural
£m |
Operational
£m |
Total
£m
|
Core Structural
£m
|
Operational
£m
|
Total
£m
|
|
New borrowings drawn down, excluding commercial paper, net of expenses
|
1,045
|
22
|
1,067
|
552
|
1
|
553
|
Repayment of borrowings, excluding commercial paper
|
(833)
|
(161)
|
(994)
|
(241)
|
(372)
|
(613)
|
Movement in commercial paper1
|
(3)
|
-
|
(3)
|
1
|
-
|
1
|
Net cash inflow/(outflow)
|
209
|
(139)
|
70
|
312
|
(371)
|
(59)
|
Foreign exchange rate movements
|
(106)
|
(2)
|
(108)
|
(132)
|
(5)
|
(137)
|
Borrowings acquired/(loans repaid) for non-cash consideration
|
1,568
|
11
|
1,579
|
-
|
(321)
|
(321)
|
Fair value movements
|
-
|
37
|
37
|
-
|
70
|
70
|
Amortisation of discounts and other non-cash items
|
(27)
|
(17)
|
(44)
|
5
|
(29)
|
(24)
|
Movements in debt held by Group companies2
|
(42)
|
(100)
|
(142)
|
-
|
1
|
1
|
Movements in the year
|
1,602
|
(210)
|
1,392
|
185
|
(655)
|
(470)
|
Balance at 1 January
|
5,310
|
2,068
|
7,378
|
5,125
|
2,723
|
7,848
|
Balance at 31 December
|
6,912
|
1,858
|
8,770
|
5,310
|
2,068
|
7,378
|
1 Gross issuances of commercial paper were £982 million in 2015 (FY14: £1,830 million), offset by repayments of £985 million (FY14: £1,829 million).
|
2 Certain subsidiary companies have purchased issued subordinated notes and securitised loan notes as part of their investment portfolios. In the consolidated statement of financial position, borrowings are shown net of these holdings but movements in such holdings over the year are reflected in the tables above.
|
2015
|
2014
|
|||||||
UK
£m
|
Ireland
£m
|
Canada
£m
|
Total
£m
|
UK
£m
|
Ireland
£m
|
Canada
£m
|
Total
£m
|
|
Total fair value of scheme assets
|
15,445
|
484
|
232
|
16,161
|
14,733
|
483
|
258
|
15,474
|
Present value of defined benefit obligation
|
(13,344)
|
(673)
|
(307)
|
(14,324)
|
(12,079)
|
(748)
|
(343)
|
(13,170)
|
Net IAS 19 surpluses/(deficits) in the schemes
|
2,101
|
(189)
|
(75)
|
1,837
|
2,654
|
(265)
|
(85)
|
2,304
|
Surpluses included in other assets
|
2,523
|
-
|
-
|
2,523
|
2,695
|
-
|
-
|
2,695
|
Deficits included in provisions
|
(422)
|
(189)
|
(75)
|
(686)
|
(41)
|
(265)
|
(85)
|
(391)
|
Net IAS 19 surpluses/(deficits) in the schemes
|
2,101
|
(189)
|
(75)
|
1,837
|
2,654
|
(265)
|
(85)
|
2,304
|
Fair Value of Scheme Assets
|
Present Value of defined benefit obligation
|
IAS 19 Pensions net surplus/ (deficits)
|
|
2015
|
£m
|
£m
|
£m
|
Net IAS 19 surplus in the schemes at 1 January
|
15,474
|
(13,170)
|
2,304
|
Past service costs - amendments
|
-
|
1
|
1
|
Administrative expenses1
|
-
|
(15)
|
(15)
|
Total pension cost charged to net operating expenses
|
-
|
(14)
|
(14)
|
Net interest credited/(charged) to investment income /(finance costs)2
|
584
|
(504)
|
80
|
Total recognised in income
|
584
|
(518)
|
66
|
Remeasurements:
|
|||
Actual return on these assets
|
99
|
-
|
99
|
Less: Interest income on scheme assets
|
(584)
|
-
|
(584)
|
Return on scheme assets excluding amounts in interest income
|
(485)
|
-
|
(485)
|
Gains from change in financial assumptions
|
-
|
234
|
234
|
Gains from change in demographic assumptions
|
-
|
3
|
3
|
Experience gains
|
-
|
13
|
13
|
Total recognised in other comprehensive income
|
(485)
|
250
|
(235)
|
Acquisitions - gross surplus
|
1,701
|
(1,633)
|
68
|
Acquisitions - consolidation elimination for non-transferable Group insurance policy3
|
(631)
|
-
|
(631)
|
Acquisitions - net deficit
|
1,070
|
(1,633)
|
(563)
|
Employer contributions
|
240
|
-
|
240
|
Plan participant contributions
|
3
|
(3)
|
-
|
Benefits paid
|
(656)
|
656
|
-
|
Administrative expenses paid from scheme assets1
|
(15)
|
15
|
-
|
Foreign exchange rate movements
|
(54)
|
79
|
25
|
Net IAS 19 surplus in the schemes at 31 December
|
16,161
|
(14,324)
|
1,837
|
1 Administrative expenses are expensed as incurred.
|
2 Net interest income of £105 million has been credited to investment income and net interest expense of £25 million has been charged to finance costs.
|
3 The gross surplus of £68 million on acquisition relates to the FPPS. As the FPPS assets include an insurance policy of £631 million at acquisition date, issued by a Group company that is not transferable under IAS 19, it is eliminated from the scheme assets.
|
Fair Value of Scheme Assets
|
Present Value of defined benefit obligation
|
IAS 19 Pensions net surplus/ (deficits)
|
|
2014
|
£m
|
£m
|
£m
|
Net IAS 19 surplus in the schemes at 1 January
|
12,398
|
(12,159)
|
239
|
Administrative expenses1
|
-
|
(27)
|
(27)
|
Total pension cost charged to net operating expenses
|
-
|
(27)
|
(27)
|
Net interest credited/(charged) to investment income /(finance costs)2
|
542
|
(522)
|
20
|
Total recognised in income from continuing operations
|
542
|
(549)
|
(7)
|
Remeasurements:
|
|||
Actual return on these assets
|
3,135
|
-
|
3,135
|
Less: Interest income on scheme assets
|
(542)
|
-
|
(542)
|
Return on scheme assets excluding amounts in interest income
|
2,593
|
-
|
2,593
|
Losses from change in financial assumptions
|
-
|
(1,063)
|
(1,063)
|
Gains from change in demographic assumptions
|
-
|
150
|
150
|
Experience losses
|
-
|
(18)
|
(18)
|
Total recognised in other comprehensive income from continuing operations
|
2,593
|
(931)
|
1,662
|
Employer contributions
|
391
|
-
|
391
|
Plan participant contributions
|
-
|
-
|
-
|
Benefits paid
|
(385)
|
385
|
-
|
Administrative expenses paid from scheme assets1
|
(27)
|
27
|
-
|
Foreign exchange rate movements
|
(38)
|
57
|
19
|
Net IAS 19 surplus in the schemes at 31 December
|
15,474
|
(13,170)
|
2,304
|
1 Administrative expenses are expensed as incurred.
|
2 Net interest income of £33 million has been credited to investment income and net interest expense of £13 million has been charged to finance costs.
|
2015
£m
|
2014
£m
|
|
Cash and cash equivalents
|
33,676
|
23,105
|
Cash and cash equivalents of operations classified as held for sale
|
-
|
9
|
Bank overdrafts
|
(506)
|
(550)
|
Net cash and cash equivalents at 31 December
|
33,170
|
22,564
|
2015
£m
|
2014
£m
|
|||||||
Income earned in the year
£m
|
Expenses incurred in the year
£m
|
Payable at year end
£m
|
Receivable at year end £m
|
Income earned in the year
£m
|
Expenses incurred in
the year
£m
|
Payable at year end
£m
|
Receivable at year end
£m
|
|
Associates
|
9
|
(7)
|
-
|
-
|
7
|
(2)
|
-
|
-
|
Joint ventures
|
27
|
-
|
-
|
192
|
28
|
-
|
-
|
154
|
Employee pension schemes
|
13
|
-
|
-
|
3
|
11
|
-
|
-
|
3
|
49
|
(7)
|
-
|
195
|
46
|
(2)
|
-
|
157
|
As at 31 December 2015
|
AAA
|
AA
|
A
|
BBB
|
Below
BBB
|
Not rated
|
Carrying value
£m
|
Debt securities
|
12.4%
|
37.4%
|
19.8%
|
21.2%
|
4.0%
|
5.2%
|
162,964
|
Reinsurance assets
|
0.1%
|
88.2%
|
8.0%
|
0.0%
|
0.0%
|
3.7%
|
20,918
|
Other investments
|
0.0%
|
0.1%
|
0.8%
|
0.0%
|
0.0%
|
99.1%
|
47,695
|
Loans
|
0.0%
|
8.2%
|
1.3%
|
0.1%
|
0.0%
|
90.4%
|
22,433
|
Total
|
254,010
|
As at 31 December 2014
|
AAA
|
AA
|
A
|
BBB
|
Below
BBB
|
Not rated
|
Carrying value
£m
|
Debt securities
|
13.6%
|
35.6%
|
21.3%
|
21.9%
|
2.1%
|
5.5%
|
131,661
|
Reinsurance assets
|
0.3%
|
71.3%
|
21.9%
|
0.1%
|
0.0%
|
6.4%
|
7,958
|
Other investments
|
0.0%
|
0.1%
|
1.3%
|
0.0%
|
0.2%
|
98.4%
|
35,358
|
Loans
|
1.3%
|
9.0%
|
2.1%
|
0.2%
|
0.0%
|
87.4%
|
25,260
|
Total
|
200,237
|
· Policy loans which are generally collateralised by a lien or charge over the underlying policy;
|
· Loans and advances to banks which primarily relate to loans of cash collateral received in stock lending transactions. These loans are fully collateralised by other securities; and
|
· Mortgage loans collateralised by property assets.
|
Financial assets that are past due but not impaired
|
|||||||
At 31 December 2015
|
Neither past due nor impaired
£m
|
0-3 months £m
|
3-6 months £m
|
6 months-
1 year
£m
|
Greater than 1 year
£m
|
Financial assets that have been impaired
£m
|
Carrying value
£m
|
Debt securities
|
918
|
-
|
-
|
-
|
-
|
-
|
918
|
Reinsurance assets
|
6,951
|
-
|
-
|
-
|
-
|
-
|
6,951
|
Other investments
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Loans
|
3,353
|
-
|
-
|
-
|
-
|
1
|
3,354
|
Receivables and other financial assets
|
6,775
|
84
|
5
|
7
|
3
|
1
|
6,875
|
Financial assets that are past due but not impaired
|
|||||||
At 31 December 2014
|
Neither past due nor impaired
£m
|
0-3 months £m
|
3-6 months £m
|
6 months-
1 year
£m
|
Greater than 1 year
£m
|
Financial assets that have been impaired
£m
|
Carrying
value
£m
|
Debt securities
|
1,021
|
-
|
-
|
-
|
-
|
-
|
1,021
|
Reinsurance assets
|
5,425
|
-
|
-
|
-
|
-
|
-
|
5,425
|
Other investments
|
1
|
-
|
-
|
-
|
-
|
4
|
5
|
Loans
|
4,286
|
2
|
2
|
-
|
-
|
75
|
4,365
|
Receivables and other financial assets
|
5,849
|
60
|
9
|
7
|
8
|
-
|
5,933
|
Sterling
£m
|
Euro
£m
|
CAD$
£m
|
Other
£m
|
Total
£m
|
|
Capital 31 December 2015
|
14,333
|
2,011
|
979
|
909
|
18,232
|
Capital 31 December 2014
|
8,050
|
2,392
|
1,016
|
818
|
12,276
|
10% increase in sterling/
euro rate
£m
|
10% decrease in sterling/
euro rate
£m
|
10% increase in sterling/
CAD$ rate
£m
|
10% decrease in sterling/
CAD$ rate
£m
|
|
Net assets at 31 December 2015
|
(166)
|
128
|
(33)
|
67
|
Net assets at 31 December 2014
|
(78)
|
210
|
(96)
|
91
|
10% increase in sterling/ euro rate
£m
|
10% decrease in sterling/ euro rate
£m
|
10% increase in sterling/ CAD$ rate
£m
|
10% decrease in sterling/ CAD$ rate
£m
|
|
Impact on profit before tax 31 December 2015
|
8
|
23
|
25
|
(46)
|
Impact on profit before tax 31 December 2014
|
(44)
|
(25)
|
(15)
|
20
|
At 31 December 2015
|
Total
£m
|
On demand or within
1 year
£m
|
1-5 years
£m
|
5-15 years £m
|
Over 15 years
£m
|
Long-term business
|
|||||
Insurance contracts - non-linked
|
114,533
|
9,847
|
30,715
|
43,513
|
30,458
|
Investment contracts - non-linked
|
63,505
|
4,506
|
13,666
|
25,477
|
19,856
|
Linked business
|
130,185
|
15,221
|
41,442
|
51,368
|
22,154
|
General insurance and health
|
13,506
|
5,844
|
5,160
|
1,992
|
510
|
Total contract liabilities
|
321,729
|
35,418
|
90,983
|
122,350
|
72,978
|
At 31 December 2014
|
Total
£m
|
On demand or within
1 year
£m
|
1-5 years
£m
|
5-15 years
£m
|
Over 15 years £m
|
Long-term business
|
|||||
Insurance contracts - non-linked
|
85,723
|
7,980
|
25,318
|
32,534
|
19,891
|
Investment contracts - non-linked
|
55,634
|
3,311
|
10,852
|
23,919
|
17,552
|
Linked business
|
75,341
|
8,141
|
21,444
|
27,673
|
18,083
|
General insurance and health
|
13,993
|
6,014
|
5,400
|
2,115
|
464
|
Total contract liabilities
|
230,691
|
25,446
|
63,014
|
86,241
|
55,990
|
At 31 December 2015
|
Total
£m
|
On demand or within
1 year
£m
|
1-5 years
£m
|
Over
5 years
£m
|
No fixed term (perpetual) £m
|
Debt securities
|
162,964
|
21,912
|
46,551
|
93,753
|
748
|
Equity securities
|
63,558
|
-
|
-
|
-
|
63,558
|
Other investments
|
47,695
|
42,733
|
940
|
2,464
|
1,558
|
Loans
|
22,433
|
1,485
|
2,404
|
18,540
|
4
|
Cash and cash equivalents
|
33,676
|
33,676
|
-
|
-
|
-
|
330,326
|
99,806
|
49,895
|
114,757
|
65,868
|
At 31 December 2014
|
Total
£m
|
On demand or within
1 year
£m
|
1-5 years
£m
|
Over
5 years £m
|
No fixed term (perpetual) £m
|
Debt securities
|
131,661
|
19,097
|
37,404
|
75,006
|
154
|
Equity securities
|
35,619
|
-
|
-
|
-
|
35,619
|
Other investments
|
35,358
|
29,011
|
940
|
3,553
|
1,854
|
Loans
|
25,260
|
1,489
|
2,517
|
21,249
|
5
|
Cash and cash equivalents
|
23,105
|
23,105
|
-
|
-
|
-
|
251,003
|
72,702
|
40,861
|
99,808
|
37,632
|
· Mortality and morbidity risks are mitigated by use of reinsurance. The Group allows businesses to select reinsurers, from those approved by the Group, based on local factors, but retains oversight of the overall exposures and monitor that the aggregation of risk ceded is within credit risk appetite.
|
· Longevity risk and internal experience analysis are monitored against the latest external industry data and emerging trends. Whilst individual businesses are responsible for reserving and pricing for annuity business, the Group monitors the exposure to this risk and any associated capital implications. The Group has used reinsurance solutions to reduce the risks from longevity and continually monitors and evaluates emerging market solutions to mitigate this risk further.
|
· Persistency risk is managed at a business unit level through frequent monitoring of company experience, and benchmarked against local market information. Generally, persistency risk arises from customers lapsing their policies earlier than has been assumed. Where possible the financial impact of lapses is reduced through appropriate product design. Businesses also implement specific initiatives to improve the retention of policies which may otherwise lapse. The Group has developed guidelines on persistency management.
|
· Expense risk is primarily managed by the business units through the assessment of business unit profitability and frequent monitoring of expense levels.
|
· Options: call, put, surrender and maturity options, guaranteed annuity options, options to cease premium payment, options for withdrawals free of market value adjustment, annuity options, and guaranteed insurability options.
|
· Guarantees: embedded floor (guaranteed return), maturity guarantee, guaranteed death benefit, and guaranteed minimum rate of annuity payment.
|
· Other: indexed interest or principal payments, maturity value, loyalty bonus.
|
· Fluctuations in the timing, frequency and severity of claims and claim settlements relative to expectations;
|
· Unexpected claims arising from a single source or cause;
|
· Inaccurate pricing of risks or inappropriate underwriting of risks when underwritten; and
|
· Inadequate reinsurance protection or other risk transfer techniques.
|
Sensitivity factor
|
Description of sensitivity factor applied
|
Interest rate and investment return
|
The impact of a change in market interest rates by a 1% increase or decrease. The test allows consistently for similar changes to investment returns and movements in the market value of backing fixed interest securities.
|
Credit spreads
|
The impact of a 0.5% increase in credit spreads over risk-free interest rates on corporate bonds and other non-sovereign credit assets. The test allows for any consequential impact on liability valuations.
|
Equity/property market values
|
The impact of a change in equity/property market values by ± 10%.
|
Expenses
|
The impact of an increase in maintenance expenses by 10%.
|
Assurance mortality/morbidity (life insurance only)
|
The impact of an increase in mortality/morbidity rates for assurance contracts by 5%.
|
Annuitant mortality (long-term insurance only)
|
The impact of a reduction in mortality rates for annuity contracts by 5%.
|
Gross loss ratios (non-long-term insurance only)
|
The impact of an increase in gross loss ratios for general insurance and health business by 5%.
|
2015 Impact on profit before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Assurance mortality +5%
|
Annuitant mortality
-5%
|
Insurance participating
|
30
|
(65)
|
(30)
|
(135)
|
130
|
(25)
|
(10)
|
(50)
|
Insurance non-participating
|
(75)
|
80
|
(495)
|
25
|
(25)
|
(155)
|
(115)
|
(725)
|
Investment participating
|
5
|
(5)
|
-
|
-
|
-
|
(5)
|
-
|
-
|
Investment non-participating
|
(20)
|
20
|
(5)
|
35
|
(35)
|
(20)
|
-
|
-
|
Assets backing life shareholders' funds
|
(140)
|
85
|
(65)
|
40
|
(40)
|
-
|
-
|
-
|
Total
|
(200)
|
115
|
(595)
|
(35)
|
30
|
(205)
|
(125)
|
(775)
|
2015 Impact on shareholders' equity before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Assurance mortality +5%
|
Annuitant mortality
-5%
|
Insurance participating
|
30
|
(65)
|
(30)
|
(135)
|
130
|
(25)
|
(10)
|
(50)
|
Insurance non-participating
|
(75)
|
80
|
(495)
|
25
|
(25)
|
(155)
|
(115)
|
(725)
|
Investment participating
|
5
|
(5)
|
-
|
-
|
-
|
(5)
|
-
|
-
|
Investment non-participating
|
(20)
|
20
|
(5)
|
35
|
(35)
|
(20)
|
-
|
-
|
Assets backing life shareholders' funds
|
(175)
|
120
|
(70)
|
40
|
(40)
|
-
|
-
|
-
|
Total
|
(235)
|
150
|
(600)
|
(35)
|
30
|
(205)
|
(125)
|
(775)
|
2014 Impact on profit before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit
spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Assurance mortality
+5%
|
Annuitant mortality
-5%
|
Insurance participating
|
(10)
|
(60)
|
(20)
|
(175)
|
70
|
(25)
|
(5)
|
(45)
|
Insurance non-participating
|
(155)
|
130
|
(425)
|
40
|
(40)
|
(80)
|
(50)
|
(590)
|
Investment participating
|
(15)
|
-
|
(10)
|
-
|
-
|
(5)
|
-
|
-
|
Investment non-participating
|
(40)
|
30
|
(10)
|
55
|
(60)
|
(35)
|
-
|
-
|
Assets backing life shareholders' funds
|
(75)
|
45
|
(60)
|
20
|
(20)
|
-
|
-
|
-
|
Total
|
(295)
|
145
|
(525)
|
(60)
|
(50)
|
(145)
|
(55)
|
(635)
|
2014 Impact on shareholders' equity before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit
spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Assurance mortality
+5%
|
Annuitant mortality
-5%
|
Insurance participating
|
(10)
|
(60)
|
(20)
|
(175)
|
70
|
(25)
|
(5)
|
(45)
|
Insurance non-participating
|
(155)
|
130
|
(425)
|
40
|
(40)
|
(80)
|
(50)
|
(590)
|
Investment participating
|
(15)
|
-
|
(10)
|
-
|
-
|
(5)
|
-
|
-
|
Investment non-participating
|
(40)
|
30
|
(10)
|
55
|
(60)
|
(35)
|
-
|
-
|
Assets backing life shareholders' funds
|
(115)
|
80
|
(65)
|
20
|
(20)
|
-
|
-
|
-
|
Total
|
(335)
|
180
|
(530)
|
(60)
|
(50)
|
(145)
|
(55)
|
(635)
|
2015 Impact on profit before tax (£m)
|
Interest rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Gross loss ratios
+5%
|
Gross of reinsurance
|
(225)
|
210
|
(130)
|
65
|
(65)
|
(100)
|
(270)
|
Net of reinsurance
|
(305)
|
300
|
(130)
|
65
|
(65)
|
(100)
|
(260)
|
2015 Impact on shareholders' equity before tax (£m)
|
Interest rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Gross loss ratios
+5%
|
Gross of reinsurance
|
(225)
|
210
|
(130)
|
70
|
(70)
|
(20)
|
(270)
|
Net of reinsurance
|
(305)
|
300
|
(130)
|
70
|
(70)
|
(20)
|
(260)
|
2014 Impact on profit before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Gross loss ratios
+5%
|
Gross of reinsurance
|
(260)
|
250
|
(130)
|
55
|
(55)
|
(105)
|
(280)
|
Net of reinsurance
|
(305)
|
295
|
(130)
|
55
|
(55)
|
(105)
|
(270)
|
2014 Impact on shareholders' equity before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit
spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Expenses +10%
|
Gross loss ratios
+5%
|
Gross of reinsurance
|
(260)
|
250
|
(130)
|
60
|
(60)
|
(20)
|
(280)
|
Net of reinsurance
|
(305)
|
295
|
(130)
|
60
|
(60)
|
(20)
|
(270)
|
2015 Impact on profit before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Total
|
-
|
-
|
10
|
(30)
|
45
|
2015 Impact on shareholders' equity before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Total
|
-
|
-
|
10
|
(30)
|
45
|
2014 Impact on profit before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit
spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Total
|
-
|
-
|
5
|
(15)
|
25
|
2014 Impact on shareholders' equity before tax (£m)
|
Interest
rates
+1%
|
Interest
rates
-1%
|
Credit
spreads +0.5%
|
Equity/ property +10%
|
Equity/ property
-10%
|
Total
|
-
|
-
|
5
|
(15)
|
25
|
Notional amount
|
2015
£m
|
2014
£m
|
5.9021% £500 million direct capital instrument - issued November 2004
|
500
|
500
|
Direct capital instrument
|
500
|
500
|
8.25% US $650 million fixed rate tier 1 notes - issued May 2012
|
392
|
392
|
6.875% £210 million STICS - issued November 2003
|
231
|
-
|
Total tier 1 notes
|
623
|
392
|
1,123
|
892
|
· Resumption of payment of coupons on the STICS; or
|
· Redemption; or
|
· The commencement of winding up of the issuer.
|
2015
£m
|
2014
£m
|
|
Acquired value of in-force business
|
4,383
|
92
|
Intangible assets
|
1,348
|
936
|
Total
|
5,731
|
1,028
|
AVIVA PLC
|
|
By: /s/ K.A. Cooper
|
|
K.A. Cooper
|
|
Group Company Secretary
|